Patent Grant
11478173
Monitoring of the level of glucose or other analytes, such as lactate or oxygen, in certain individuals is vitally important to their health. High or low levels of glucose or other analytes may have detrimental effects. Monitoring of glucose is particularly important to individuals with diabetes. Diabetics may need to monitor glucose levels to determine when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies. In non-diabetic individuals, it may be important to monitor glycemic responses to determine whether therapeutic approaches may be useful to prevent the onset of diabetes.
Analyte monitoring systems may be designed to test blood samples taken periodically and measured outside of the body (in vitro testing), such as by putting a drop of blood on a test strip, and performing an analyte analysis on the test strip. Blood may be taken from a finger (by performing a “fingerstick”) or other locations on the body, such as the arm, thigh, etc. Tests performed in such a manner may be referred to as “discrete” measurements, and in the case of glucose measurements, “blood glucose” (BG) measurements. Other systems are designed to measure analyte levels within the body (in vivo), using a suitable sensor, without drawing blood for every measurement. Certain systems have combined functionality for performing both sensor-based as well as discrete measurements.
In some situations, it is medically desirable to monitor analyte levels in a subject closely, over a substantial period of time, or on an ongoing basis for an extended time period, in some cases indefinitely. A monitor that tracks glucose levels by automatically taking periodic in vivo measurements, e.g., one measurement per minute, or more or less frequently, is known as a “continuous glucose monitor” (CGM). Prior art CGMs have been provided, for example, in the form of a system. A portion of the system, comprising an electrochemical sensor partially inserted into the skin, and an associated processor and transmitter, with a self-contained power supply, is attached to the body of the user and will remain in place for an extended period of hours, days, weeks, etc. The transmitter takes analyte measurements periodically and transmits them, for example, by short-range radio communications, to a separate receiver/display device. The receiver/display device will typically receive discrete BG measurements (e.g., from a separate BG meter or an included BG test strip port), as well as a port, such as a USB port, for communications with upstream computers and/or other electronics. In some embodiments, the receiver unit may be directly or indirectly interfaced with an insulin pump, for managing the subject's insulin therapy.
The accuracy of the analyte measurements obtained with an in vivo sensing system is important. Calibration of such systems may be performed by comparing in vivo “system” measurements against discrete BG “reference” measurements from fingerstick samples measured on a test strip.
CGM systems typically perform calibrations on a fixed schedule. However, such a fixed schedule may impose inconvenience on the user if a required calibration occurs when a user is occupied with other activities or asleep. In some instances a required calibration may occur when analyte levels are in a state of instability or rapid change. Calibrations taken during such times of unstable analyte levels may sometimes provide less than optimal results. Accordingly, it would be desirable to provide calibration routines which allow customization by user. It would also be desirable to provide calibration routines which calibrate when the analyte levels and rates of change are more desirable for accurate measurement and observation.
An analyte measurement system and a method for calibrating a signal from an electrochemical sensor are provided. A signal is generated from the sensor, which corresponds to an analyte concentration level in a biofluid of a subject. A user interface prompts a user to assay a calibration sample of the user's blood to obtain a calibration value if a first condition is met. A processor is configured to correlate the calibration value to at least one of the signals from the sensor if the first condition is met.
In some embodiments the method further includes selecting a first time frame. In some embodiments, the method includes selecting a maximum number of calibrations in the first time frame. The first condition may be met if fewer than the maximum number of calibrations has occurred in the first time frame.
In some embodiments the method further includes selecting a second time frame. The method may include selecting a maximum number of calibrations in the second time frame. The first condition may be met if fewer than the maximum number of calibrations has occurred in the second time frame.
In some embodiments, the method further includes prompting the user to assay a calibration sample of the user's blood to obtain a calibration value if a second condition is met. The method may further include allowing the user to select a time period in which calibrations are not accepted. The second condition may be met if the current time is outside the selected time period.
In some embodiments, the system further includes prompting the user to assay a calibration sample of the user's blood to obtain a calibration value, if a third condition is met. The method may include determining the existence of a condition relating the subject. In some embodiments, the condition comprises a determination of whether the subject is asleep. The third condition may be met if the condition does not exist. In some embodiments, the analyte is glucose.
In some embodiments, the assayed calibration sample is obtained from a finger stick testing site. In some embodiments, the assayed calibration sample is obtained from an alternative site test. The location of the assayed calibration sample may be the leg of a user, or the abdomen of a user. Obtaining the calibration measurement may include determining the calibration measurement in less than or equal to about 1 L of blood. In some embodiments, the calibration value is compared to at least one signal from the sensor for use in calibrating the sensor.
An analyte measurement system and a method for calibrating a signal from an electrochemical sensor is provided, which includes generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject; providing a user the option to select a time for obtaining a calibration sample of the user's blood to obtain a calibration value; and correlating the calibration value to at least one of the signals from the sensor if the current time corresponds to the selected time.
In some embodiments, the method includes providing a user an option to select a time comprises providing a user the option to select a date and a time for calibration. The method may include providing a user an option to select a time comprises providing a user the option to select a time for recurrent daily calibration. In some embodiments, the analyte is glucose.
An analyte measurement system and a method for calibrating a signal from an electrochemical sensor is provided which includes generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject; determining whether calibration is accepted; and providing a user the option to obtain a calibration sample of the user's blood to obtain a calibration value if calibration is accepted; and correlating the calibration value to at least one of the signals from the sensor.
In some embodiments, the predetermined time is fifteen minutes. In some embodiments, calibration is accepted if the rate of change of the signal is within a predetermined threshold. The method may further include determining the likelihood of successful calibration. In some embodiments, an icon is provided in a display unit relating to the likelihood of successful calibration.
An analyte measurement system and a method for calibrating a signal from an electrochemical sensor is provided which includes generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject; determining a predetermined calibration time; determining a prospective calibration window running prior to the predetermined calibration time; and allowing calibration if a reference analyte measurement is available during the prospective calibration window.
In some embodiments, the method includes providing a grace period after the predetermined calibration time, and providing an alarm if no calibration is performed during the time period beginning with the predetermined calibration time and ending with the expiration of the grace period. In some embodiments, the alarm is suppressed if a reference analyte measurement is available during the prospective calibration window.
In some embodiments, the user is notified if a reference analyte measurement is being accepted for calibration.
In some embodiments, the prospective calibration window comprises a time period of 10 minutes, 30 minutes prior, or one hour prior to the predetermined calibration time.
An analyte measurement system and a method for calibrating a signal from an electrochemical sensor is provided which includes generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject; determining a condition relating to the stability of the sensor signal; and allowing calibration if the sensor stability is within a predetermined threshold.
In some embodiments, the predetermined threshold comprises a sensor stability of about 1 mg/dL/min. In some embodiments, the method further includes determining the duration of sensor operation and determining stability of the sensor signal at a reference duration of sensor operation. A calibration may be requested if the stability of the sensor signal at the reference duration of sensor operation is below a threshold. The reference duration of sensor operation may refer to an elapsed time following insertion of the sensor in the subject. In some embodiments, the reference duration comprises four hours.
A detailed description of various aspects, features, and embodiments of the subject matter described herein is provided with reference to the accompanying drawings, which are briefly described below. The drawings are illustrative and are not necessarily drawn to scale, with some components and features being exaggerated for clarity. The drawings illustrate various aspects and features of the present subject matter and may illustrate one or more embodiment(s) or example(s) of the present subject matter in whole or in part. Like reference numerals used in different figures denote like components or process steps. Reference numerals that differ only in the hundreds or thousands place from reference numerals in earlier figures refer (unless the context requires otherwise) to components or process steps that may be adapted from the corresponding component or process step in the prior Figure.
A detailed description of the disclosure is provided herein. It should be understood, in connection with the following description, that the subject matter is not limited to particular embodiments described, as the particular embodiments of the subject matter may of course vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the disclosed subject matter will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosed subject matter. Every range stated is also intended to specifically disclose each and every “sub range” of the stated range. That is, each and every range smaller than the outside range specified by the outside upper and outside lower limits given for a range, whose upper and lower limits are within the range from said outside lower limit to said outside upper limit (unless the context clearly dictates otherwise), is also to be understood as encompassed within the disclosed subject matter, subject to any specifically excluded range or limit within the stated range. Where a range is stated by specifying one or both of an upper and lower limit, ranges excluding either or both of those stated limits, or including one or both of them, are also encompassed within the disclosed subject matter, regardless of whether or not words such as “from”, “to”, “through”, or “including” are or are not used in describing the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosed subject matter belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosed subject matter, this disclosure may specifically mention certain exemplary methods and materials.
All publications mentioned in this disclosure are, unless otherwise specified, incorporated herein by reference for all purposes, including without limitation to disclose and describe the methods and/or materials in connection with which the publications are cited.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosed subject matter is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates, which may need to be independently confirmed.
As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
Nothing contained in the Abstract or the Summary should be understood as limiting the scope of the disclosure. The Abstract and the Summary are provided for bibliographic and convenience purposes and due to their formats and purposes should not be considered comprehensive.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosed subject matter. Any recited method can be carried out in the order of events recited, or in any other order which is logically possible. Reference to a singular item, includes the possibility that there are plural of the same item present. When two or more items (for example, elements or processes) are referenced by an alternative “or”, this indicates that either could be present separately or any combination of them could be present together except where the presence of one necessarily excludes the other or others.
Certain classes of analyte monitors are provided in small, lightweight, battery-powered and electronically-controlled systems. Such a system may be configured to detect signals indicative of in vivo analyte levels using an electrochemical sensor, and to process and/or collect such signals. In some embodiments, the portion of the system that performs this initial processing may be configured to transmit the initially processed data to another unit for further collection and/or processing. Such transmission may be affected, for example, via a wired connection, such as electrical contacts or a cable, or via a wireless connection, such as an IR or RF connection.
Certain analyte monitoring systems for in vivo measurement employ a sensor that measures analyte levels in interstitial fluids under the surface of the subject's skin. In certain embodiments, a sensor may be inserted transcutaneously or subcutaneously (i.e., at least partially through the skin), or, in other embodiments, may be inserted entirely or wholly implanted below the skin. A sensor in such a system may operate as an electrochemical cell. Such a sensor may use any of a variety of electrode configurations, such as a three-electrode configuration (e.g., with “working”, “reference” and “counter” electrodes), driven by a controlled potential (potentiostat) analog circuit, a two-electrode system configuration (e.g., with only working and counter electrodes), which may be self-biasing and/or self-powered, and/or other configurations.
In certain systems, the analyte sensor is in communication with a data processing/transmitter unit; the term “transmitter unit” or “transmitter device” as used in this disclosure sometimes refers to such a combination of an analyte sensor with such a data processing/transmitter unit. Certain embodiments are modular. The transmitter device may be separately provided as a physically distinct assembly, and configured to transmit the analyte levels detected by the sensor over a communication link to a receiver/monitor unit, referred to in this disclosure as a “receiver unit” or “receiver device”, or in some contexts, depending on the usage, as a “display unit,” “handheld unit,” or “meter”.
The receiver unit may perform data analysis, etc. on the received analyte data to generate information pertaining to the monitored analyte levels. The receiver unit may incorporate a display screen, which can be used, for example, to display measured analyte levels. It is also useful for a user of an analyte monitor to be able to see trend indications (including the magnitude and direction of any ongoing trend), and such data may be displayed as well, either numerically, or by a visual indicator, such as an arrow that may vary in visual attributes, such as size, shape, color, animation, or direction. The receiver device may further incorporate a test strip port and related electronics in order to be able to make discrete (e.g., BG) measurements.
The modularity of these systems may vary. In some embodiments the sensor is attachable and detachable from the transmitter (and transmitter reusable), while in other embodiments, the sensor and transmitter may be provided as an integrated package, which may be disposable.
To provide flexibility in analyte sensor manufacturing and/or design, it may be desirable for the transmitter device to accommodate a substantial range of analyte sensor sensitivities. Methods and systems for measuring sensor sensitivity are desirable in such cases, so that the analyte monitor may be accurately calibrated.
In certain embodiments, system 100 may be a continuous glucose monitoring (CGM) system, and accordingly operate in a mode in which the communications via connection 130 have sufficient range to support a flow of data from on-body unit 101 to monitor unit 140. In some embodiments, the data flow in a CGM system is automatically provided by the on-body unit 101 to the monitor unit 140. For example, no user intervention may be required for the on-body unit 101 to send the data to the monitor unit 140. In some embodiments, the on-body unit 101 provides the signal relating to analyte level to the monitor unit 140 on a periodic basis. For example, the signal may be provided, e.g., automatically sent, on a fixed schedule, e.g., once every 250 ms, once a second, once a minute, etc. In some embodiments, the signal is provided to the monitor unit 140 upon the occurrence of an event, e.g., a hyperglycemic event or a hypoglycemic event, etc. In some embodiments, data processing unit 120 may further include local memory in which it may record “logged data” or buffered data collected over a period of time and provide the some or all of the accumulated data to monitor unit 140 periodically. In other embodiments, a separate data logging unit may be provided to acquire periodically transmitted data from data processing unit 120. Data transmission in a CGM system may be one-way communication, e.g., the on-body unit 101 provides data to the monitor unit 140 without receiving signals from the monitor unit 140. In some embodiments, two-way communication is provided between the on-body unit 101 and the monitor unit 140.
In some embodiments, a signal is provided to the monitor unit 140 “on demand.” According to such embodiments, the monitor unit 140 requests a signal from the on-body unit 101, or the on-body unit 101 may be activated to send signal upon activation to do so. Accordingly, one or both of the on-body unit 101 and monitor unit 140 may include a switch activatable by a user or activated upon some other action or event, the activation of which causes analyte-related signals to be transferred from the on-body unit 101 to the monitor unit 140. For example, the monitor unit 140 is placed in close proximity with a transmitter device and initiates a data transfer, either over a wired connection, or wirelessly by various means, including, for example, various RF-carried encodings and protocols, such as radio frequency identification (RFID) protocols, and IR links.
In some embodiments, the signal relating to analyte level is instantaneously generated by the analyte sensor 110 upon receipt of the request, and transmitted to the monitor unit 140 as requested, and/or the signal relating to analyte level is periodically obtained, e.g., once every 250 ms, once a second, once a minute, etc. Upon receipt of the “on demand” request at the on-body unit 101, an analyte signal is provided to the monitor unit. In some cases, the signal provided to the monitor unit 140 includes the most recent analyte signal(s).
In further embodiments, additional data is provided to the monitor unit 140 “on demand.” For example, analyte trend data may be provided. Such trend data may include two or more analyte data points to indicate that analyte levels are rising, falling, or stable. Analyte trend data may include data from longer periods of time, such as, e.g., several minutes, several hours, several days, or several weeks.
Further details regarding CGM and on demand systems are disclosed in, for example, U.S. Pat. No. 7,620,438, U.S. Patent Publication No. 2009/0054749 A1, published Feb. 26, 2009; 2007/0149873 A1, published Jun. 28, 2007, now U.S. Pat. No. 9,014,773; 2008/0064937 A1, published Mar. 13, 2008; 2008/0071157 A1, published Mar. 20, 2008; 2008/0071158 A1, published Mar. 20, 2008; 2009/0281406 A1, published Nov. 12, 2009; 2008/0058625 A1, published Mar. 6, 2008, now U.S. Pat. No. 7,920,907; 2009/0294277 A1, published Dec. 3, 2009; 2008/0319295 A1, published Dec. 25, 2008, now U.S. Pat. No. 8,597,188; 2008/0319296 A1, published Dec. 25, 2008, now U.S. Pat. No. 8,617,069; 2009/0257911 A1, published Oct. 15, 2009, now U.S. Pat. No. 8,252,229; 2008/0179187 A1, published Jul. 31, 2008, now U.S. Pat. No. 8,808,515; 2007/0149875 A1, published Jun. 28, 2007, now U.S. Pat. No. 8,515,518; 2009/0018425 A1, published Jan. 15, 2009, now U.S. Pat. No. 8,160,670; and U.S. patent application Ser. No. 12/625,524, filed Nov. 24, 2009, now U.S. Pat. No. 8,390,455; Ser. No. 12/625,525, filed Nov. 24, 2009, now U.S. Pat. No. 8,358,210; Ser. No. 12/625,528, filed Nov. 24, 2009, now U.S. Pat. No. 8,115,635; Ser. No. 12/628,201, filed Nov. 30, 2009; Ser. No. 12/628,177, filed Nov. 30, 2009; Ser. No. 12/628,198, filed Nov. 30, 2009; Ser. No. 12/628,203, filed Nov. 30, 2009; Ser. No. 12/628,210, filed Nov. 30, 2009; Ser. No. 12/393,921, filed Feb. 26, 2009; Ser. No. 12/698,124, filed Feb. 1, 2010; Ser. No. 12/495,709, filed Jun. 30, 2009; Ser. No. 12/714,439, filed Feb. 26, 2010; Ser. No. 12/842,013, filed Jul. 22, 2010, now U.S. Pat. No. 9,795,326; 61/163,006, filed Mar. 23, 2009; Ser. No. 12/495,730, filed Jun. 30, 2009; Ser. No. 12/495,712, filed Jun. 30, 2009, now U.S. Pat. No. 8,437,827; Ser. No. 12/807,278, filed Aug. 31, 2010; Ser. No. 12/873,301, filed Aug. 31, 2010; Ser. No. 12/870,818, filed Aug. 28, 2010; Ser. No. 12/873,302, filed Aug. 31, 2010; 61/249,535, filed Oct. 7, 2009; Ser. No. 12/544,061, filed Aug. 19, 2009; Ser. No. 12/625,185, filed Nov. 24, 2009, now U.S. Pat. No. 8,354,013; Ser. No. 12/625,208, filed Nov. 24, 2009, now U.S. Pat. No. 9,042,954; Ser. No. 12/624,767, filed Nov. 24, 2009; Ser. No. 12/242,780, filed Sep. 30, 2008, now U.S. Pat. No. 8,983,568; Ser. No. 12/183,602, filed Jul. 31, 2008; Ser. No. 12/211,014, filed Sep. 15, 2008, now U.S. Pat. No. 8,636,884; and Ser. No. 12/114,359, filed May 2, 2008, now U.S. Pat. No. 8,080,385, each of which is incorporated by reference in its entirety herein for all purposes.
An exemplary configuration for sensor 110 and data processing unit 120 (e.g., collectively on-body unit 101) is illustrated in
In some embodiments, sensor 110 is disposed within the on-body unit 101, in a bent configuration. The contact portion of sensor 110 is oriented in a substantially horizontal configuration, and secured to a circuit board of on-body unit 101. The insertion portion 214 of the sensor 110 extends in a downwardly vertical orientation for placement in the skin of the subject. It is understood that sensor 110 may be disposed in other configurations, e.g., in an entirely substantially vertical configuration. As a further example, the insertion portion 214 may be disposed at an oblique angle, e.g., between 0° and 90° with respect to the skin surface.
As illustrated in
The receiver unit 140 may perform data analysis, etc., on the received analyte data to generate information pertaining to the monitored analyte levels. The receiver unit may incorporate a display screen 221, which can be used, for example, to display measured analyte levels. It is also useful for a user of an analyte monitor to be able to see trend indications (including the magnitude and direction of any ongoing trend), and such data may be displayed as well, either numerically, or by a visual indicator, such as an arrow that may vary in visual attributes, such as size, shape, color, animation, or direction. The receiver device may further incorporate a test strip port 222 and related electronics in order to be able to make discrete (e.g., BG) measurements.
The modularity of these systems may vary. In some embodiments the sensor is attachable and detachable from the transmitter (and transmitter reusable), while in other embodiments, the sensor and transmitter may be provided as an integrated package, which may be disposable.
To provide flexibility in analyte sensor manufacturing and/or design, it may be desirable for the transmitter device to accommodate a substantial range of analyte sensor sensitivities. Methods and systems for measuring sensor sensitivity are desirable in such cases, so that the analyte monitor may be accurately calibrated. In the present invention, novel methods for measuring sensor sensitivity are provided, as described below.
The sensor 110 of the analyte measurement system 100 may be used to monitor levels of a wide variety of analytes. Analytes that may be monitored include, for example, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored.
In one embodiment of the present disclosure, sensor 110 is physically positioned in or on the body of a user whose analyte level is being monitored. Sensor 110 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level into a corresponding data signal for analysis and/or transmission by data processing unit 120. Alternatively, sensor 110 may be configured to provide analyte levels on demand, e.g., upon request, from a separate device.
The sensor 110 may take on a number of forms. For example, the sensor 110 may include a flexible or rigid substrate. In some embodiments, the sensor 110 may be a wire. In some embodiments, the sensor 110 may include two or three or more electrodes.
In some embodiments, sensor 110 includes a substrate which is a dielectric, e.g., a polymer or plastic material, such as polyester or polyamide. In certain embodiments, the sensor 110 is constructed so that a portion is positionable beneath skin and a portion is above skin. Accordingly, sensor 110 includes an insertion portion and a contact portion. The contact portion typically includes several conductive contacts for connection to other electronics, e.g., at the data processing unit 120. In certain embodiments, the contacts provided are for a working electrode, a reference electrode, and a counter electrode. In some embodiments, two or more working electrodes are provided. The operative portions of these electrodes, that is, the working electrode, reference electrode, and counter electrode, are provided at the distal end of insertion portion of sensor 110. The contact and operative portions of the electrodes are connected by circuit traces running on the surface of the substrate. In some embodiments, the traces are provided in channels, or may be embedded within the substrate, or may traverse different sides of the substrate. The conductive contacts, conductive traces, and electrodes are fabricated from a conductive material, such as platinum, palladium, gold, or conductive carbon. Further details of sensors are described, e.g., in U.S. Pat. Nos. 6,175,572, 6,103,033, and 6,134,461, the disclosures of each of which are incorporated by reference herein.
In use, the sensor 110 may be configured to bend and therefore be positioned in two substantially perpendicular, intersecting planes.
In general, sensors in accordance with the present disclosure operate electrochemically, through an arrangement of electrodes having chemical sensing layers applied thereto, by generating an electrical current proportional to the volume of a redox reaction of the analyte (and indicative of analyte concentration), catalyzed by an analyte-specific oxidizing enzyme. Embodiments exist in which the number of electrodes provided to bring about and detect the level of these reactions is two, three or a greater number.
A portion of sensor 110 may be situated above the surface of the skin, with a distal portion 214 penetrating through the skin and into the subcutaneous space in contact with the user's biofluid, such as interstitial fluid. The disposition of the sensor in the illustrated embodiment is referred to as “transcutaneous” or “subcutaneous”. In general, the terms “transcutaneous” and “subcutaneous” as used herein refer to a sensor that is only partially inserted under one or more layers of the skin of the user. In certain embodiments, sensor 110 is completely inserted under one or more layers of the skin of the user, i.e., wholly implanted beneath the skin surface. It is understood that many features described herein would be applicable to transcutaneous and subcutaneous sensors as well as wholly implanted sensors. Further details regarding the electrochemistry of sensor 110 is provided in, for example, U.S. Pat. Nos. 5,264,104; 5,356,786; 5,262,035; 5,320,725; 5,593,852; and 6,990,366, the disclosures of each of which are incorporated herein by reference for all purposes.
In some embodiments, the sensor is implantable into a subject's body for a period of time (e.g., three to seven days, or in some embodiments, longer periods of up to several weeks) to contact and monitor an analyte present in a biological fluid. In this regard, the sensor can be disposed in a subject at a variety of sites (e.g., abdomen, upper arm, thigh, etc.), including intramuscularly, transcutaneously, intravascularly, or in a body cavity.
In some embodiments, sensor 110 is employed by insertion and/or implantation into a user's body for some usage period. In such embodiments, the substrate may be formed from a relatively flexible material to improve comfort for the user and reduce damage to the surrounding tissue of the insertion site, e.g., by reducing relative movement of the sensor with respect to the surrounding tissue.
Certain embodiments of sensor 110 include three electrodes, while other embodiments can include a fewer or greater number of electrodes. For example, a two electrode sensor can be utilized. The sensor may be externally-powered and allow a current to pass proportional to the amount of analyte present. Alternatively, the sensor itself may act as a current source in some embodiments. In some two-electrode embodiments, the sensor may be self-biasing and there may be no need for a reference electrode. An exemplary self-powered, two-electrode sensor is described in U.S. patent application Ser. No. 12/393,921, filed Feb. 26, 2009, and entitled “Self-Powered Analyte Sensor,” which is hereby incorporated by reference in its entirety herein for all purposes. The level of current provided by a self-powered sensor may be low, for example, on the order of nanoamperes.
The logic 322 portion of processor 321 can be implemented in several different ways. Processor 321 could comprise a general purpose computer, such as an embedded microprocessor, which could operate by executing machine-readable routines stored in memory 323. In such a case, logic 322 comprises the general purpose processing elements of processor 321, programmed to perform specific functions by the programming read from memory 323. Memory 323 could comprise read-only memory or firmware, or volatile memory loaded from a storage device (not shown), either at system startup (boot) or during run time. Alternatively, logic 322 could comprise a system of logic elements interconnected to perform the specified operations. Such a system could be provided in the form of discrete hard-wired logic, gate arrays, programmable gate arrays, and might include one or more Field Programmable Gate Arrays (FPGAs) or Application-Specific Integrated Circuits (ASICs).
For a more detailed discussion of continuous analyte monitoring devices, see, e.g., U.S. patent application Ser. No. 12/873,298, filed Aug. 31, 2010, now U.S. Pat. No. 8,993,331, hereby incorporated by reference herein in its entirety, for all purposes. Additional commonly assigned applications describe systems which comprise an “on-demand” analyte monitor, e.g., in which analyte measurements are either transmitted from the sensor/transmitter to the receiver unit or obtained from the sensor upon request of the user. See, e.g., U.S. patent application Ser. No. 13/011,898 filed Jan. 22, 2011 and U.S. patent application Ser. No. 12/807,278 filed Aug. 31, 2010, the disclosures of each of which are hereby incorporated by reference in their entirety herein for all purposes.
System 300 may also comprise an operative component configured to provide a reference analyte measurement. Such a component may be an analyte meter. The analyte meter may be a glucose meter comprising a test strip port. As shown in
In some embodiments, processor 321 includes logic 322 to perform the following functions: accept a reference analyte measurement of the subject, made other than with said sensor, perform, in response to a command from the user of the system, at least one test measurement of a level of analyte in the subject, and if the test measurement is performed within about a specified period before or after said noted time of said reference measurement, determine a calibration adjustment for use with said system, as a function of the reference measurement and the test measurement.
The logic 322 provided by processor 321 may cause a prompt to be provided to the user to perform a reference analyte measurement, such as a BG measurement from a finger stick. Such a prompt could be provided based on a calibration schedule established in system 300. The logic causes the system to accept the reference test if it satisfies specified criteria, as described above. If the reference test satisfies the specified criteria, the logic might further provide another prompt to be provided to the user, to perform a test analyte measurement using system 300. The logic might further provide the capability, through a suitable setup routine or otherwise, for the user to enable or disable issuance of an explicit prompt to perform the system measurement.
In some embodiments, the system requires the user to perform calibrations on a fixed schedule. For example, several calibrations may be scheduled on the first day of sensor wear, e.g., the first twenty-four hours following implantation of the sensor. Calibrations are typically required to address peculiarities of wearing a sensor under the skin on the first day. Without limiting the current disclosure, such peculiarities may be due to several mechanisms, such as the healing characteristics of the subject's body, the sensor chemistry, etc. In some embodiments, a pre-set calibration schedule is typically established at the factory and includes several times in which a calibration request is sent to a user. A user is typically unable to alter such calibration schedule. Such calibration schedule may be referred to herein as a “pre-set calibration schedule.”
Proper calibration of a glucose monitor with a reference glucose reading is vital for accurate performance in certain embodiments. Calibration is the process where the conversion factor for the calculation of glucose from sensor data is determined, where the conversion factor (or sensitivity) is a ratio of the electrical current generated by the analyte sensor to the reference glucose value associated in line with this current signal.
To perform calibration based on discrete measurements, analyte monitoring system 100 may employ a substantial plurality of signal processing algorithms, which may be performed by a processor within data processing unit 120 and/or a processor in receiver unit 140, or a combination of those processors. Over the usable life of sensor 110, calibrations may be performed at various intervals in order to determine that the sensor is ready for use and continues to operate in a useful range, and to determine the sensitivity of the sensor so that accurate analyte concentration measurements may be provided.
Relevant functions that may be provided with regard to calibration may fall into two areas: (1) logic for scheduling calibrations, and (2) logic for performing calibrations.
The reference measurement may be a BG finger stick (in the case of the analyte being glucose), but also may be any measurement of analyte in the subject, blood-based or otherwise, taken by any means other than the system being calibrated.
The procedure for taking a system measurement is further outlined in
Data processing or transmitter units may vary from one to another in terms of electrical and physical characteristics. Accordingly, the sensor current measurement may be adjusted for variations among processing units in accordance with parameters that characterize the particular data processing unit in use (520). The current may then be further subjected to temperature compensation (530) and, if sufficient data is available, lag time compensation (540), the latter being applied due to the delay in interstitial analyte concentration measurements as compared to discrete blood measurements, when the analyte level is changing.
An “immediate, real-time” sensitivity factor may be calculated (550) by dividing the temperature and lag-corrected sensor current by the reference measurement (each determined at appropriate times). Furthermore, a composite sensitivity may be calculated based on successive measurements, for example, two successive measurements, by performing a weighted average of the sensitivities calculated from the two measurements.
Note, however, that in order to proceed with any of the processing described above, it is also desirable to perform a plurality of tests (in some embodiments, a substantial plurality of tests), to ensure that the data utilized in the sensitivity determination (550) is valid. These validation checks will be described in connection with the more detailed discussion of calibration procedures that follows.
In an on-demand system, certain adaptations will be introduced into the processing described in connection with
With the foregoing in mind, with regard to inherent differences between CGM and on-demand operating characteristics, the steps shown in
The calibration process in the illustrated embodiment begins with either a scheduled or user-initiated calibration (610). In these embodiments, analyte measurement system 100 expects calibration when either a scheduled calibration is due, or the user indicates intent to perform manual calibration, for example, by appropriate input into a CGM monitor, or alternatively by initiating an on-demand measurement.
The electrical current produced by analyte sensor 110, the temperature of the skin near the sensor, and the temperature of the circuitry may be checked for validity within data processing unit 120. Whenever data processing unit 120 is connected to receiver unit 140 (whether on a “continuous” basis or in an on-demand connection), these measurements and checks are transmitted to the receiver unit. In some embodiments, the data processing unit 120 transmits data to the receiver unit 140 via a “rolling data” field in a periodic data packet. Data may be spread out among consecutive data packets, and the packets may provide redundancy (and further reliability and data integrity) by accompanying current values with immediate past values. Other embodiments, e.g., in which the transmitter collects logged and/or time-delayed data, may transfer larger amounts of data with each transmission. See, e.g., U.S. patent application Ser. No. 12/807,278, filed on Aug. 31, 2010, which is hereby incorporated by reference herein in its entirety for all purposes. Data transmitted may include measurement calibration information and a “count” of the sensor measurement from an analog to digital converter (ADC).
After a calibration is initiated, a calibration preconditions check (611) may be performed. In one embodiment, these checks may include data validation on the transmitter side, including checks for hardware error (a composite OR of a plurality of possible error signals), data quality (set if the sensor measurement is changing faster than could be accounted for physiologically, indicative of an intermittent connection or leakage) and current/voltage saturation (compared to current and voltage thresholds). If any of these conditions are detected and then cleared, the corresponding flag bit remains set for a period, e.g., one minute, after the condition clears, to give time for the system to settle.
Further checks may be performed within receiver unit 140. A counter electrode voltage signal may be checked to ensure that it is within operating range, and if not the receiver processor may set a flag for invalid data not to be used for measurements (and hold the flag for a period, e.g., one minute, after the condition clears).
A data quality check may further comprise checks that all requisite data has been supplied by the transmitter; that none of the various error flags are set; and that the current and prior voltage counts were within prescribed limits (e.g., about 50-2900 voltage counts). There may be further validation that the transmitter temperature is in a valid range (e.g., about 25-40° C.), that raw sensor current is above an acceptable threshold (e.g., about 18 counts, minimum), and that sensor life state (provided by other logic in the system) is still active. There may also be a further check for high-frequency noise.
A data availability check may be performed. In this check, after eliminating points marked as invalid per the above-described processes, as well as those invalidated by upstream processes, a determination is made whether there are sufficient valid data points to reliably perform rate-related calculations, as may be required in various aspects of the calibration procedure. The data availability check may be varied for on-demand applications: they may be based on an examination of stored data received in the latest transmission (where the transmitter stores data or provides time-delayed data), or alternatively, these tests could be reduced or eliminated.
A minimum wait requirement check may be performed, to ensure that the calibration request does not conflict with the operative calibration schedule (As will be discussed, calibration scheduling imposes limitations on when calibrations may be taken and/or used, including waiting periods during baseline calibrations and at certain other times).
A sensor rate check may also be performed. A rate is calculated from a plurality of measurement points, based on a least-squares straight-line fit, again, where data is available. The value of the rate thus established must be less than the composite sensitivity (or if not yet calculated, a nominal sensitivity) multiplied by the sensor current.
Pre-calibration check procedures are further discussed in commonly assigned U.S. Publication No. 2008/0161666 and U.S. Publication No. 2009/0036747, which are hereby each incorporated by reference in their entirety herein for all purposes.
If conditions permit (or require) calibration, and calibration is called for or expected in accordance with a calibration schedule, or user initiated, a calibration attempt may be requested (612). Calibration “attempt” for purposes hereof means that a reference measurement is used or evaluated for calibration purposes. In some embodiments, requesting a calibration attempt comprises providing a prompt, for example, through a screen on receiver unit 140, or an audible prompt, to take a reference measurement, e.g., a BG fingerstick.
After the user has conducted a reference measurement for calibration (620), further checks may be performed, to check the sensor condition since the request for the reference test was made, and to ensure that the reference measurement is within an acceptable range (630). Such checks may further comprise the same tests as the pre-calibration checks, except that user interaction delays will not be factored into rate windows and determinations, and scheduling wait time constraints will not be considered (since the calibration has already started).
Post-calibration check procedures are further discussed in commonly assigned U.S. Publication No. 2008/0161666 and U.S. Publication No. 2009/0036747, referred to above.
After reference test data is acquired and checked, sensor sensitivity may be determined (640). Measured sensor current may be affected by a number of factors, for which appropriate corrections may be introduced.
As mentioned above in connection with
A lag adjustment between interstitial fluid and blood glucose values may also be calculated. In comparing a measured interstitial analyte measurement with a blood-derived reference measurement, in a subject whose analyte level may be changing, there could be a time lag of the interstitial measurement as compared to the blood-based reference measurement, which could affect the accuracy of the calibration unless appropriately taken into account. In one embodiment, the lag corrected monitored data at the calibration time may be determined by applying the determined rate of change of the monitored data at the calibration time to a predetermined constant value. In one embodiment, the predetermined constant value may include, a predetermined time constant. For example, in one embodiment, the predetermined time constant may include a fixed time constant in the range of approximately four to fifteen minutes, and which may be associated with the one or more of the patient physiological profile, one or more attributes associated with the monitoring system (including, for example, but not limited to, the characteristics of the analyte sensor 110). In a further aspect, the predetermined time constant may vary based on one or more factors including, for example, but not limited to, the timing and amount of food intake by the patient, exogenous insulin intake, physical activities by the patient such as exercise, or any other factors that may affect the time constant, and which may be empirically determined. See U.S. Publication No. 2008/0081977, now U.S. Pat. No. 7,618,369, which is hereby incorporated herein by reference in its entirety for all purposes. Where only fewer data points are available, other rate calculations may be used. In addition, analog rate measurements may be made and transmitted as separate measurements.
In certain embodiments, signal attenuation may also affect sensor readings. “Early Signal Attenuation” (ESA) refers to a condition in which the effective signals representing an analyte level measured by a sensor appears to attenuate and then recover in the early stages of the sensor life. For example, for some embodiments, the sensor signals of the system may attenuate during the first 24 hours after insertion. Some embodiments employ one or more procedures to detect this state to avoid giving inaccurate readings while the system is in an ESA condition. The states that may be defined with respect to ESA, and the transitions between those states, are discussed below in connection with calibration scheduling. As will be further addressed in that discussion, ESA detection may be performed (650), in some embodiments, primarily during periods in which ESA is likely to occur, e.g., within the first 24 hours after insertion. ESA detection procedures are further described in commonly assigned U.S. patent application Ser. No. 12/363,712, now U.S. Pat. No. 8,346,335, which is hereby incorporated by reference in its entirety herein for all purposes.
In certain embodiments, two calibration sensitivity tests are performed (660) after passing the ESA tests described above: an absolute test, and a relative (outlier) test. In the absolute sensitivity test, the measured immediate sensitivity is compared to the nominal sensitivity for the sensor. The relative sensitivity test is intended to eliminate “outlier” measurements from being used to calculate composite sensitivity. As will be discussed in the next section, a composite sensitivity calculation, in some embodiments, requires two sensitivity figures, S1 and S2. Si(k), Si(k-1), and Si(m) are chosen in connection with ESA. If Si(k)/Si(k-1) (e.g., current valid sensitivity compared to preceding valid sensitivity) is in the range of about 0.778 to 1.5, then Si(k-1) (the prior value) will be used as S1, and Si(k) (the current value) will be used as S2. If the foregoing test fails, then, if there is an S(m) established, and if Si(k) compared to the previously determined composite sensitivity (Sc) falls within the above range, then Si(m) will be used for S1 and Si(k) will be used as S2. Otherwise, another calibration attempt is requested, for which Si(k) will become Si(k-1), and as part of the new determination, the relative (outlier) test will be repeated. These procedures are further described in commonly assigned U.S. Publication No. 2009/0036747, which is hereby incorporated by reference in its entirety herein for all purposes.
The computed composite sensitivity (670), Sc, is used to convert sensor current in units of ADC counts to calibrated analyte (e.g., glucose) levels in units of mg/dL in some embodiments. For the first calibration, the composite sensitivity is equal to the sensitivity from a single valid calibration attempt. When appropriate thereafter, multiple sensitivities are used to determine the composite sensitivity.
For the first calibration, the composite sensitivity takes the value of Si(k). Afterwards, the composite sensitivity is a weighted average of the S1 and S2 values determined by the outlier check:
Sc(k)=S1W1+S2W2
The first weighting parameter and the second weighted parameter may be different or substantially equal. They may, for example, be one or both of time based, or based on a prior calibration parameter. In certain embodiments, the weighing factors used are about 0.4, 0.42, 0.433, 0.444, etc. for W1, and 0.6, 0.58, 0.567, 0.556, etc. for W2. In some embodiments, the weighting factors may depend upon when the analyte measurement was taken, e.g., more recent analyte measurements may be assigned a larger weighting factor.
Sc may need to be updated between calibrations, as a result of a pseudo-retrospective immediate sensitivity adjustment, in which case S2 will be replaced with a new value from that adjustment.
During operation of receiver unit 140, a calibrated analyte concentration figure (GCAL) may be obtained using the currently valid composite sensitivity:
GCAL=GtTC/SC
The latest immediate sensitivity value S2 used to calculate composite sensitivity incorporates, as discussed, a lag correction to take into account the delay between a change in blood analyte level and a corresponding change in the interstitial level of the analyte. However, if analyte levels continue to change after a calibration, it may be possible, in some embodiments, to improve the lag correction by factoring in system measurements taken after the calibration, and use the improved correction to update S2, and, correspondingly, Sc. This correction is based on subsequent system measurements, and accordingly may be done without taking a new reference measurement (e.g., fingerstick).
In certain embodiments, this correction, referred to as a pseudo-retrospective immediate sensitivity correction (680), is calculated after about seven system measurements have been taken after the prior calibration (provided no subsequent calibration attempt becomes eligible for update before this number of system measurements have been collected), of which at least about four are valid. Alternatively, the retrospective data could be provided by a subsequent on-demand system measurement. If the standard error associated with computing the adjusted analyte count is less than the standard error in the underlying lag correction calculation (e.g., an improved correction is indicated), the sensitivity used for S2 may be updated accordingly.
To perform the correction, a new least-squares fitted line may be determined, taking into account the additional post-calibration data system measurements, and the slope (rate) and intercept of this line used to calculate a corrected value (GPrLrTC) for the real time value GRtLrTC, which may be divided by the reference measurement from the latest attempt to obtain an updated sensitivity to use as S2.
These procedures for calculating a pseudo-retrospective immediate sensitivity correction are further described in commonly assigned U.S. Publication No. 2008/0081977, now U.S. Pat. No. 7,618,369, which is hereby incorporated by reference in its entirety herein for all purposes.
As noted, if a pseudo-retrospective immediate sensitivity correction is performed, resulting in an updated value for S2, then a corresponding update composite sensitivity factor, Sc, may be calculated (690). The value of S1 used in the earlier calculation of Sc will continue to be used.
Further description of the procedures outlined in
In some embodiments, filtering may be performed before the analyte level is displayed. In an on-demand setting, filtering may be accomplished by using analog-averaged values, or by performing calculations for a series of stored values transmitted as a batch and filtering those values as above.
On-demand monitors will generally not automatically perform system measurements after a discrete calibration attempt, because such monitors inherently rely on the user to initiate a system measurement, e.g., by bringing receiver unit 140 into proximity of on-body unit 101 and/or providing a user input, such as pressing a button. Referring to
The system causes a reference measurement of a level of said analyte in the subject to be performed by a method other than use of the system being calibrated (710). The system causes the user to use the on-demand system to perform at least one test measurement of a level of said analyte (730), within about a specified period before or after the time of the reference measurement (720). The system determines a calibration adjustment, as a function of at least said reference measurement and said at least one test measurement (740). The reference measurement in the foregoing protocol could be caused to be conducted at a time in accordance with a calibration schedule for the in-demand device.
An optional method for sensor calibration may comprise the following steps: (a) factory determination of sensor sensitivity, (b) factory assignment of sensor calibration number, (c) user enters factory calibration number into on-demand RX, (d) on-demand Tx measurement of sensor current and temperature, and (e) software in RX determines corrected glucose.
For calibration schemes where sensor data prior to and substantially proximate to the calibration BG reading are used in the sensitivity calculation, a more detailed adapted calibration procedure could be used as shown in
The foregoing procedure differs from a CGM calibration procedure, e.g., in its prompts and in how the on-demand test measurement is acquired. In a CGM implementation, the CGM data may be acquired continuously or intermittently, and are typically available prior to the reference measurement.
A variation of the above procedure might be employed where an on-demand measurement is acquired prior to but recent to the reference measurement. In such a case, the system may check for this and not prompt the subject, and use the on-demand measurement that had already been acquired. Alternatively, the procedure may not use an explicit prompt, but the user could be instructed to perform the on-demand test measurement without the prompt. Furthermore, the receiver unit could provide the option of whether to include the prompt or not.
The on-demand test measurement may include one or more sensor measurements. These measurements may be temporal signal samples in the past, lagged measurements of the sensor signal such as can be achieved by measuring the same signal lagged by an RC circuit, or any other form of signal measurements including measurement of multiple signals. For example, sensor temperature may also be measured. As previously mentioned, specific embodiments for acquiring periodic, averaged and rate-of-change data from a transmitter device in the context of an on-demand measurement are discussed further below.
Some CGM calibration protocols use sensor data acquired prior to, substantially proximate to, and after the reference test reading in the sensitivity calculation. For example, in some embodiments, CGM data subsequent to a BG reading may be used to improve the lag correction included in the calibration method. Such data may be used to update the calibration at some time, for example about seven minutes, after the BG reading.
In certain embodiments, additional steps may be implemented to increase the accuracy of the calibration. After the new sensitivity factor is generated (860), after a predetermined time after the reference measurement (870), the receiver unit prompts the user to acquire another on-demand test measurement (880). The receiver unit uses the newly acquired on-demand test measurement to generate an updated sensitivity factor (890). This process may use the previously acquired on-demand data and reference measurement, or only the previous sensitivity results; other processing variations are possible as appropriate.
If the on-demand system has the capability of transmitting periodic, averaged or rate-of-change information based on a sequence of measurements preceding the on-demand transmission, then that additional data will be available for use in connection with the above-described update, to further refine the update.
As discussed above, prompts are provided to the user to perform a reference analyte measurement. In some embodiments, if the user does not perform the reference measurement within a grace period, the system will not provide sensor readings until the next calibration measurement is performed. Similarly, if a requested calibration is failed, for any number of reasons (e.g., glucose outside of desirable range for calibration), the system will not accept the blood glucose measurement as a valid calibration and will not provide sensor readings and may prompt the user to perform additional calibration attempts.
As a result, the timing of the calibration requests can be unpredictable, which can be frustrating to the user of the system. Calibration requests that frequently repeat or that occur during a fixed schedule may occur at inopportune times. A technique is provided which imposes limits on the system calibration requests to make the calibration algorithm more user-friendly.
As illustrated in
The second level is a cap on the number of calibration requests issued in a longer period of time (TE)2, such as a day. In some embodiments, the second time period may be derived from a reasonable assessment of the limit in the number of blood glucose measurements a user would typically be willing to perform in a given day in the absence of continuous glucose monitoring. As illustrated in
As illustrated in
As illustrated in
In certain embodiments, conditions other than sleeping may be detected. For example, during periods of activity, such as during exercise, calibration may be inconvenient to the user and further, calibration during such times may be inaccurate. The system may detect conditions associated with such bodily conditions, such as by monitoring body temperature, blood pressure or the pulse of the user. In certain embodiments, a user or a user's physician or care provider may have the option of programming particular bodily parameters associated with conditions during which time calibration is not to be requested.
In further embodiments, calibrations are performed at times determined by the user, in addition to or in substitution of, the pre-set calibration schedule. Such user-determined calibration may take into account that there are particular times of day where it is optimal for the user to calibrate. For example, exemplary optimal times to calibrate can include in the morning before leaving the house for work, or at night before going to bed.
In some embodiments, the user-determined calibration can require that the user take some action to calibrate on a user-determined schedule. If the user takes no action, then the system defaults to the pre-set calibration schedule.
When the user uses a user-determined calibration schedule, the algorithm typically adjusts the pre-set calibration schedule (e.g., if the calibration occurred after the first day, the next pre-set calibration would be scheduled to occur 48 hours after the just completed user-determined calibration).
As illustrated in
In the first variation, the user schedules the date and time of 1 to n calibrations in advance (1310). In this variation, the user could access a screen on the receiver unit that showed the upcoming calibration times. The user would be allowed to edit or delete these times (within the rules of the algorithm as discussed herein) and would be allowed to add new times.
In the second variation, the user sets 1 to 2 times of days when they want to calibrate (1320). For each time, the user would be allowed to specify whether that calibration was to occur daily or every 2 days.
As illustrated in
When the system will accept a calibration, the user is notified (1430). According to some embodiments, an icon or some other indicator is added to the system that notifies the user. The system may also determine the likelihood that a calibration will succeed (1420). The system provides the user with the likelihood that the calibration will succeed (1440). Additionally a color coded icon could be used in some embodiments to indicate the likelihood that a calibration will succeed. After providing the notifications, the system provides the user with the option of scheduling calibration (1450). If the user elects to calibrate, such calibration is scheduled (1460).
In some embodiments, calibrations are required to occur at one or more scheduled calibration time(s). For example, preset intervals may be provided, e.g., that calibration occurs at 24 hours, 48 hours, and 72 hours after sensor insertion, etc. In other embodiments, scheduled calibration times may be every 12 hours after sensor insertion. A grace period may be provided after the scheduled calibration time of about, e.g., about 30 minutes, about one hour, about 90 minutes. A grace period of about 2 hours, about 6 hours, about 8 hours, about 12 hours, etc., is provided for subsequent attempts in certain embodiments. An alarm may be provided to the user if no calibration occurs at either scheduled calibration time, or at the expiration of the grace period to require the user to perform the calibration.
A user may take a reference analyte measurement at various times during the use of the system. However, the reference analyte measurement is typically not accepted for calibration except during these schedule calibration times and the subsequent grace period.
In some embodiments, a time window is provided preceding the scheduled calibration time. As illustrated in
In some embodiments, if a reference analyte measurement is available, the system accepts the measurement for calibration if the current time T is within the calibration window. In some embodiments, the system provides an indication (e.g., visual or audible) that calibration will be accepted, regardless of whether a reference analyte measurement is available.
If the user provides a reference analyte measurement, such as a finger stick during the calibration window and calibrates the system, the alarm is suppressed that normally sounds if no calibration occurs at the predetermined calibration time or within the grace period.
In some embodiments, the system requests calibration based upon the stability of the sensor signal over time. Thus, as illustrated in
In the event of an apparent rapid sensor equilibration before a first time period, e.g., about four hours, the receiver would then prompt the user to do an additional calibration measurement subsequently, e.g., at about two hours, four hours, six hours, ten hours, twelve hours, etc.
Furthermore, the logic within the system may operate to cause the user to perform an additional system measurement, some time after the first or prior system measurement, for example, five minutes, or seven minutes, or ten minutes, or some other period after, and could provide functions to update the system calibration adjustment based on the additional system measurement. The updated calibration adjustment may be calculated by the logic as a function of at least the additional system measurement, the prior system measurement and the reference measurement. Alternatively, the updated calibration adjustment may be calculated by the logic as a function of the additional system measurement and a prior calibration adjustment.
Additionally, the system measurements used by the logic for calibrating device may comprise temporal signal samples acquired in the past, or time-lagged measurements of the sensor signal, such as may be obtained from a RC network coupled to an analyte sensor. Furthermore, the logic could provide for incorporating other measurements, such as skin and sensor temperature measurements, which could be acquired individually or as part of a data transmission from transmitter device containing multiple measurements.
Additional detailed description of the continuous analyte monitoring system, its various components including the functional descriptions of the transmitter are provided in U.S. Pat. No. 6,175,752 issued Jan. 16, 2001 entitled “Analyte Monitoring Device and Methods of Use”, and in U.S. patent application Ser. No. 10/745,878 filed Dec. 26, 2003, now U.S. Pat. No. 7,811,231, entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application, and each of which are incorporated herein by reference for all purposes.
In certain embodiments, a method for calibrating a signal from an electrochemical sensor may comprise generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject, prompting a user to assay a calibration sample of the user's blood to obtain a calibration value, if a first condition is met, and correlating the calibration value to at least one of the signals from the sensor if the first condition of is met.
Certain aspects may include selecting a first time frame.
Certain aspects may include selecting a maximum number of calibrations in the first time frame.
In certain aspects, the first condition may be met if fewer than the maximum number of calibrations have occurred in the first time frame.
Certain aspects may include selecting a second time frame.
Certain aspects may include selecting a maximum number of calibrations in the second time frame.
In certain aspects, the first condition may be met if fewer than the maximum number of calibrations have occurred in the second time frame.
Certain aspects may include prompting the user to assay a calibration sample of the user's blood to obtain a calibration value, if a second condition is met.
Certain aspects may include allowing the user to select a time period in which calibrations are not accepted.
In certain aspects, the second condition may be met if the current time is outside the selected time period.
Certain aspects may include prompting the user to assay a calibration sample of the user's blood to obtain a calibration value, if a third condition is met.
Certain aspects may include determining the existence of a condition relating the subject.
In certain aspects, the condition may include a determination of whether the subject is asleep.
In certain aspects, the third condition may be met if the condition does not exist.
In certain embodiments of the present disclosure, a method for calibrating a signal from an electrochemical sensor may comprise generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject, providing a user the option to select a time for obtaining a calibration sample of the user's blood to obtain a calibration value, and correlating the calibration value to at least one of the signals from the sensor if the current time corresponds to the selected time.
In certain aspects, providing a user an option to select a time may include providing a user the option to select a date and a time for calibration.
In certain aspects, providing a user an option to select a time may include providing a user the option to select a time for recurrent daily calibration.
In certain embodiments of the present disclosure, a method for calibrating a signal from an electrochemical sensor may include generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject, determining whether calibration is accepted, providing a user the option to obtain a calibration sample of the user's blood to obtain a calibration value if calibration is accepted, and correlating the calibration value to at least one of the signals from the sensor.
In certain aspects, the predetermined time may be fifteen minutes
In certain aspects, the calibration may be accepted if the rate of change of the signal is within a predetermined threshold.
Certain aspects may include determining the likelihood of successful calibration.
In certain aspects, an icon may be provided in a display unit relating to the likelihood of successful calibration.
In certain embodiments, a method for calibrating a signal from an electrochemical sensor may include generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject, determining a predetermined calibration time, determining a prospective calibration window running prior to the predetermined calibration time, and allowing calibration if a reference analyte measurement is available during the prospective calibration window.
Certain aspects may include providing a grace period after the predetermined calibration time, and providing an alarm if no calibration is performed during the time period beginning with the predetermined calibration time and ending with the expiration of the grace period.
Certain aspects may include suppressing the alarm if a reference analyte measurement is available during the prospective calibration window.
Certain aspects may include notifying the user if a reference analyte measurement is being accepted for calibration.
In certain aspects, the prospective calibration window may include a time period of 10 minutes prior to the predetermined calibration time.
In certain aspects, the prospective calibration window may include a time period of 30 minutes prior to the predetermined calibration time.
In certain aspects, the prospective calibration window may include a time period of one hour prior to the predetermined calibration time.
In certain embodiments, a method for calibrating a signal from an electrochemical sensor may include generating a signal from the sensor, the signal corresponding to an analyte concentration level in a biofluid of a subject, determining a condition relating to the stability of the sensor signal, and allowing calibration if the sensor stability is within a predetermined threshold.
In certain aspects, the predetermined threshold may include a sensor stability of about 1 mg/dL/min.
Certain aspects may include determining a duration of sensor operation and determining stability of the sensor signal at a reference duration of sensor operation.
Certain aspects may include requesting a calibration if the stability of the sensor signal at the reference duration of sensor operation is below a threshold.
In certain aspects, the reference duration of sensor operation may include an elapsed time following insertion of the sensor in the subject.
In certain aspects, the reference duration may include four hours.
In certain embodiments, an analyte measurement system may include an electrochemical sensor generating a signal corresponding to an analyte concentration level in a biofluid of a subject, and a processor unit comprising a user interface for prompting a user to assay a calibration sample of the user's blood to obtain a calibration value, if a first condition is met; and configured to correlate the calibration value to at least one of the signals from the sensor if the first condition of is met.
In certain aspects, the user interface may provide an option for selecting a first time frame.
In certain aspects, the user interface may provide an option for selecting a maximum number of calibrations in the first time frame.
In certain aspects, the first condition may be met if fewer than the maximum number of calibrations have occurred in the first time frame.
In certain aspects, the user interface may provide an option for selecting a second time frame.
In certain aspects, the user interface may provide an option for selecting a maximum number of calibrations in the second time frame.
In certain aspects, the first condition may be met if fewer than the maximum number of calibrations have occurred in the second time frame.
In certain aspects, the user interface may be configured to prompt the user to assay a calibration sample of the user's blood to obtain a calibration value, if a second condition is met.
In certain aspects, the user interface may provide an option for allowing the user to select a time period in which calibrations are not accepted.
In certain aspects, the second condition may be met if the current time is outside the selected time period.
In certain aspects, the user interface may be configured to prompt the user to assay a calibration sample of the user's blood to obtain a calibration value, if a third condition is met.
In certain aspects, the user interface may be configured to determine the existence of a condition relating the subject.
In certain aspects, the condition may include a determination of whether the subject is asleep
In certain aspects, the third condition may be met if the condition does not exist.
In certain embodiments, an analyte measurement system may include an electrochemical sensor generating a signal corresponding to an analyte concentration level in a biofluid of a subject, and a processor unit comprising a user interface for prompting a user to select a time for obtaining a calibration sample of the user's blood to obtain a calibration value; and configured to correlate the calibration value to at least one of the signals from the sensor if the current time corresponds to the selected time.
In certain aspects, the user interface may be configured to prompt the user to select a date and a time for calibration.
In certain aspects, the user interface may be configured to prompt the user to select a time for recurrent daily calibration.
In certain embodiments, an analyte measurement system may include an electrochemical sensor generating a signal corresponding to an analyte concentration level in a biofluid of a subject, a processor configured to determine whether calibration is accepted, and a user interface providing a user the option to obtain a calibration sample of the user's blood to obtain a calibration value if calibration is accepted and wherein the processor is configured to correlate the calibration value to at least one of the signals from the sensor.
In certain aspects, the predetermined time may be fifteen minutes.
In certain aspects, the calibration may be accepted if the rate of change of the signal is within a predetermined threshold.
In certain aspects, the processor may be configured to determine the likelihood of successful calibration.
In certain aspects, the user interface may be configured to provide an icon relating to the likelihood of successful calibration.
In certain embodiments, an analyte measurement system may include an electrochemical sensor generating a signal corresponding to an analyte concentration level in a biofluid of a subject, a processor configured to determine a predetermined calibration time, to determine a prospective calibration window running prior to the predetermined calibration time, and to allow calibration if a reference analyte measurement is available during the prospective calibration window.
In certain aspects, processor may be configured to provide a grace period after the predetermined calibration time, and provide an alarm if no calibration is performed during the time period beginning with the predetermined calibration time and ending with the expiration of the grace period.
In certain aspects, processor may be configured to suppress the alarm if a reference analyte measurement is available during the prospective calibration window.
In certain aspects, the user interface may be configured notify the user if a reference analyte measurement is being accepted for calibration.
In certain aspects, the prospective calibration window may include a time period of 10 minutes prior to the predetermined calibration time.
In certain aspects, the prospective calibration window may include a time period of 30 minutes prior to the predetermined calibration time.
In certain aspects, the prospective calibration window may include a time period of one hour prior to the predetermined calibration time.
In certain embodiments, an analyte measurement system may include an electrochemical sensor generating a signal corresponding to an analyte concentration level in a biofluid of a subject, a processor configured to determine a condition relating to the stability of the sensor signal, and to allow calibration if the sensor stability is within a predetermined threshold.
In certain aspects, the predetermined threshold may include a sensor stability of about 1 mg/dL/min.
In certain aspects, a duration of sensor operation and the stability of the sensor signal at a reference duration of sensor operation may be determined.
In certain aspects, the user interface may request a calibration if the stability of the sensor signal at the reference duration of sensor operation is below a threshold.
In certain aspects, the reference duration of sensor operation may include an elapsed time following insertion of the sensor in the subject.
In certain aspects, the reference duration may include four hours.
In certain aspects, the analyte may be glucose.
In certain aspects, the assayed calibration sample may be obtained from a fingerstick testing site.
In certain aspects, the assayed calibration sample may be obtained from an alternative site test.
In certain aspects, the location may be located along a leg of a user.
In certain aspects, the location may be located along an abdomen of a user.
In certain aspects, obtaining the calibration measurement may include determining the calibration measurement in less than or equal to about 1 L of blood.
In certain aspects, the calibration value may be compared to at least one signal from the sensor for use in calibrating the sensor.
While the present disclosure has been described with reference to the specific embodiments thereof, it should be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the true spirit and scope of the present disclosure. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process step or steps, to the objective, spirit and scope of the present disclosure. All such modifications are intended to be within the scope of the claims appended hereto.
The present application is a continuation of U.S. patent application Ser. No. 13/172,823 filed Jun. 29, 2011, now U.S. Pat. No. 10,092,229, which claims the benefit of U.S. Provisional Application No. 61/359,774 filed Jun. 29, 2010 entitled “Calibration of Analyte Measurement System,” the disclosures of each of which are incorporated herein by reference for all purposes.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3581062 | Aston | May 1971 | A |
| 3926760 | Allen et al. | Dec 1975 | A |
| 3949388 | Fuller | Apr 1976 | A |
| 3960497 | Acord et al. | Jun 1976 | A |
| 3978856 | Michel | Sep 1976 | A |
| 4036749 | Anderson | Jul 1977 | A |
| 4055175 | Clemens et al. | Oct 1977 | A |
| 4129128 | McFarlane | Dec 1978 | A |
| 4245634 | Albisser et al. | Jan 1981 | A |
| 4327725 | Cortese et al. | May 1982 | A |
| 4344438 | Schultz | Aug 1982 | A |
| 4349728 | Phillips et al. | Sep 1982 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4392849 | Petre et al. | Jul 1983 | A |
| 4425920 | Bourland et al. | Jan 1984 | A |
| 4441968 | Emmer et al. | Apr 1984 | A |
| 4462048 | Ross | Jul 1984 | A |
| 4478976 | Goertz et al. | Oct 1984 | A |
| 4494950 | Fischell | Jan 1985 | A |
| 4509531 | Ward | Apr 1985 | A |
| 4527240 | Kvitash | Jul 1985 | A |
| 4538616 | Rogoff | Sep 1985 | A |
| 4545382 | Higgins et al. | Oct 1985 | A |
| 4619793 | Lee | Oct 1986 | A |
| 4671288 | Gough | Jun 1987 | A |
| 4703756 | Gough et al. | Nov 1987 | A |
| 4711245 | Higgins et al. | Dec 1987 | A |
| 4731051 | Fischell | Mar 1988 | A |
| 4731726 | Allen, III | Mar 1988 | A |
| 4749985 | Corsberg | Jun 1988 | A |
| 4757022 | Shults et al. | Jul 1988 | A |
| 4759366 | Callaghan | Jul 1988 | A |
| 4777953 | Ash et al. | Oct 1988 | A |
| 4779618 | Mund et al. | Oct 1988 | A |
| 4854322 | Ash et al. | Aug 1989 | A |
| 4871351 | Feingold | Oct 1989 | A |
| 4890620 | Gough | Jan 1990 | A |
| 4925268 | Iyer et al. | May 1990 | A |
| 4947845 | Davis | Aug 1990 | A |
| 4953552 | DeMarzo | Sep 1990 | A |
| 4986271 | Wilkins | Jan 1991 | A |
| 4995402 | Smith et al. | Feb 1991 | A |
| 5000180 | Kuypers et al. | Mar 1991 | A |
| 5002054 | Ash et al. | Mar 1991 | A |
| 5019974 | Beckers | May 1991 | A |
| 5050612 | Matsumura | Sep 1991 | A |
| 5055171 | Peck | Oct 1991 | A |
| 5068536 | Rosenthal | Nov 1991 | A |
| 5077476 | Rosenthal | Dec 1991 | A |
| 5082550 | Rishpon et al. | Jan 1992 | A |
| 5106365 | Hernandez | Apr 1992 | A |
| 5113869 | Nappholz et al. | May 1992 | A |
| 5122925 | Inpyn | Jun 1992 | A |
| 5135004 | Adams et al. | Aug 1992 | A |
| 5148812 | Verrier et al. | Sep 1992 | A |
| 5165407 | Wilson et al. | Nov 1992 | A |
| 5199428 | Obel et al. | Apr 1993 | A |
| 5202261 | Musho et al. | Apr 1993 | A |
| 5203326 | Collins | Apr 1993 | A |
| 5204264 | Kaminer et al. | Apr 1993 | A |
| 5210778 | Massart | May 1993 | A |
| 5231988 | Wernicke et al. | Aug 1993 | A |
| 5246867 | Lakowicz et al. | Sep 1993 | A |
| 5262035 | Gregg et al. | Nov 1993 | A |
| 5262305 | Heller et al. | Nov 1993 | A |
| 5264104 | Gregg et al. | Nov 1993 | A |
| 5264105 | Gregg et al. | Nov 1993 | A |
| 5279294 | Anderson et al. | Jan 1994 | A |
| 5285792 | Sjoquist et al. | Feb 1994 | A |
| 5293877 | O'Hara et al. | Mar 1994 | A |
| 5299571 | Mastrototaro | Apr 1994 | A |
| 5313953 | Yomtov et al. | May 1994 | A |
| 5320715 | Berg | Jun 1994 | A |
| 5320725 | Gregg et al. | Jun 1994 | A |
| 5322063 | Allen et al. | Jun 1994 | A |
| 5328460 | Lord et al. | Jul 1994 | A |
| 5330634 | Wong et al. | Jul 1994 | A |
| 5340722 | Wolfbeis et al. | Aug 1994 | A |
| 5342789 | Chick et al. | Aug 1994 | A |
| 5356786 | Heller et al. | Oct 1994 | A |
| 5360404 | Novacek et al. | Nov 1994 | A |
| 5365426 | Siegel et al. | Nov 1994 | A |
| 5372427 | Padovani et al. | Dec 1994 | A |
| 5376070 | Purvis et al. | Dec 1994 | A |
| 5379238 | Stark | Jan 1995 | A |
| 5384547 | Lynk et al. | Jan 1995 | A |
| 5390671 | Lord et al. | Feb 1995 | A |
| 5391250 | Cheney, II et al. | Feb 1995 | A |
| 5400795 | Murphy et al. | Mar 1995 | A |
| 5408999 | Singh et al. | Apr 1995 | A |
| 5411647 | Johnson et al. | May 1995 | A |
| 5425749 | Adams | Jun 1995 | A |
| 5425868 | Pedersen | Jun 1995 | A |
| 5431160 | Wilkins | Jul 1995 | A |
| 5431921 | Thombre | Jul 1995 | A |
| 5438983 | Falcone | Aug 1995 | A |
| 5462645 | Albery et al. | Oct 1995 | A |
| 5472317 | Field et al. | Dec 1995 | A |
| 5489414 | Schreiber et al. | Feb 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5505828 | Wong et al. | Apr 1996 | A |
| 5507288 | Bocker et al. | Apr 1996 | A |
| 5509410 | Hill et al. | Apr 1996 | A |
| 5514718 | Lewis et al. | May 1996 | A |
| 5520191 | Karlsson et al. | May 1996 | A |
| 5531878 | Vadgama et al. | Jul 1996 | A |
| 5543326 | Heller et al. | Aug 1996 | A |
| 5552997 | Massart | Sep 1996 | A |
| 5568400 | Stark et al. | Oct 1996 | A |
| 5568806 | Cheney, II et al. | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5582184 | Erickson et al. | Dec 1996 | A |
| 5586553 | Halili et al. | Dec 1996 | A |
| 5593852 | Heller et al. | Jan 1997 | A |
| 5601435 | Quy | Feb 1997 | A |
| 5609575 | Larson et al. | Mar 1997 | A |
| 5628310 | Rao et al. | May 1997 | A |
| 5628890 | Carter et al. | May 1997 | A |
| 5640954 | Pfeiffer et al. | Jun 1997 | A |
| 5653239 | Pompei et al. | Aug 1997 | A |
| 5660163 | Schulman et al. | Aug 1997 | A |
| 5665222 | Heller et al. | Sep 1997 | A |
| 5711001 | Bussan et al. | Jan 1998 | A |
| 5711861 | Ward et al. | Jan 1998 | A |
| 5720295 | Greenhut et al. | Feb 1998 | A |
| 5733259 | Valcke et al. | Mar 1998 | A |
| 5735285 | Albert et al. | Apr 1998 | A |
| 5741211 | Renirie et al. | Apr 1998 | A |
| 5772586 | Heinonen et al. | Jun 1998 | A |
| 5785660 | van Lake et al. | Jul 1998 | A |
| 5791344 | Schulman et al. | Aug 1998 | A |
| 5792065 | Xue et al. | Aug 1998 | A |
| 5820551 | Hill et al. | Oct 1998 | A |
| 5822715 | Worthington et al. | Oct 1998 | A |
| 5891047 | Lander et al. | Apr 1999 | A |
| 5899855 | Brown | May 1999 | A |
| 5914026 | Blubaugh, Jr. et al. | Jun 1999 | A |
| 5918603 | Brown | Jul 1999 | A |
| 5925021 | Castellano et al. | Jul 1999 | A |
| 5935224 | Svancarek et al. | Aug 1999 | A |
| 5942979 | Luppino | Aug 1999 | A |
| 5957854 | Besson et al. | Sep 1999 | A |
| 5960797 | Kramer et al. | Oct 1999 | A |
| 5961451 | Reber et al. | Oct 1999 | A |
| 5964993 | Blubaugh, Jr. et al. | Oct 1999 | A |
| 5965380 | Heller et al. | Oct 1999 | A |
| 5971922 | Arita et al. | Oct 1999 | A |
| 5995860 | Sun et al. | Nov 1999 | A |
| 6001067 | Shults et al. | Dec 1999 | A |
| 6016443 | Ekwall et al. | Jan 2000 | A |
| 6021350 | Mathson | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6038469 | Karlsson et al. | Mar 2000 | A |
| 6049727 | Crothall | Apr 2000 | A |
| 6071391 | Gotoh et al. | Jun 2000 | A |
| 6073031 | Helstab et al. | Jun 2000 | A |
| 6083710 | Heller et al. | Jul 2000 | A |
| 6088608 | Schulman et al. | Jul 2000 | A |
| 6091976 | Pfeiffer et al. | Jul 2000 | A |
| 6093172 | Funderburk et al. | Jul 2000 | A |
| 6103033 | Say et al. | Aug 2000 | A |
| 6108577 | Benser | Aug 2000 | A |
| 6112116 | Fischell | Aug 2000 | A |
| 6115622 | Minoz | Sep 2000 | A |
| 6115628 | Stadler et al. | Sep 2000 | A |
| 6117290 | Say et al. | Sep 2000 | A |
| 6119028 | Schulman et al. | Sep 2000 | A |
| 6120676 | Heller et al. | Sep 2000 | A |
| 6121009 | Heller et al. | Sep 2000 | A |
| 6121611 | Lindsay et al. | Sep 2000 | A |
| 6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
| 6128526 | Stadler et al. | Oct 2000 | A |
| 6134461 | Say et al. | Oct 2000 | A |
| 6143164 | Heller et al. | Nov 2000 | A |
| 6144837 | Quy | Nov 2000 | A |
| 6159147 | Lichter et al. | Dec 2000 | A |
| 6161095 | Brown | Dec 2000 | A |
| 6162611 | Heller et al. | Dec 2000 | A |
| 6175752 | Say et al. | Jan 2001 | B1 |
| 6200265 | Walsh et al. | Mar 2001 | B1 |
| 6212416 | Ward et al. | Apr 2001 | B1 |
| 6219574 | Cormier et al. | Apr 2001 | B1 |
| 6223283 | Chaiken et al. | Apr 2001 | B1 |
| 6233471 | Berner et al. | May 2001 | B1 |
| 6233486 | Ekwall et al. | May 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6249705 | Snell | Jun 2001 | B1 |
| 6254586 | Mann et al. | Jul 2001 | B1 |
| 6256538 | Ekwall | Jul 2001 | B1 |
| 6264606 | Ekwall et al. | Jul 2001 | B1 |
| 6270455 | Brown | Aug 2001 | B1 |
| 6272379 | Fischell et al. | Aug 2001 | B1 |
| 6275717 | Gross et al. | Aug 2001 | B1 |
| 6283761 | Joao | Sep 2001 | B1 |
| 6284478 | Heller et al. | Sep 2001 | B1 |
| 6293925 | Safabash et al. | Sep 2001 | B1 |
| 6295506 | Heinonen et al. | Sep 2001 | B1 |
| 6299757 | Feldman et al. | Oct 2001 | B1 |
| 6306104 | Cunningham et al. | Oct 2001 | B1 |
| 6309884 | Cooper et al. | Oct 2001 | B1 |
| 6329161 | Heller et al. | Dec 2001 | B1 |
| 6338790 | Feldman et al. | Jan 2002 | B1 |
| 6348640 | Navot et al. | Feb 2002 | B1 |
| 6359444 | Grimes | Mar 2002 | B1 |
| 6360888 | McIvor et al. | Mar 2002 | B1 |
| 6361503 | Starobin et al. | Mar 2002 | B1 |
| 6366794 | Moussy et al. | Apr 2002 | B1 |
| 6377828 | Chaiken et al. | Apr 2002 | B1 |
| 6377852 | Bornzin et al. | Apr 2002 | B1 |
| 6377894 | Deweese et al. | Apr 2002 | B1 |
| 6379301 | Worthington et al. | Apr 2002 | B1 |
| 6381493 | Stadler et al. | Apr 2002 | B1 |
| 6387048 | Schulman et al. | May 2002 | B1 |
| 6405066 | Essenpreis et al. | Jun 2002 | B1 |
| 6413393 | Van Antwerp et al. | Jul 2002 | B1 |
| 6424847 | Mastrototaro et al. | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6440068 | Brown et al. | Aug 2002 | B1 |
| 6461496 | Feldman et al. | Oct 2002 | B1 |
| 6471689 | Joseph et al. | Oct 2002 | B1 |
| 6478736 | Mault | Nov 2002 | B1 |
| 6484046 | Say et al. | Nov 2002 | B1 |
| 6501983 | Natarajan et al. | Dec 2002 | B1 |
| 6503381 | Gotoh et al. | Jan 2003 | B1 |
| 6514460 | Fendrock | Feb 2003 | B1 |
| 6514718 | Heller et al. | Feb 2003 | B2 |
| 6520326 | McIvor et al. | Feb 2003 | B2 |
| 6540891 | Stewart et al. | Apr 2003 | B1 |
| 6544212 | Galley et al. | Apr 2003 | B2 |
| 6551494 | Heller et al. | Apr 2003 | B1 |
| 6558320 | Causey, III et al. | May 2003 | B1 |
| 6558321 | Burd et al. | May 2003 | B1 |
| 6558351 | Steil et al. | May 2003 | B1 |
| 6560471 | Heller et al. | May 2003 | B1 |
| 6561978 | Conn et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6565509 | Say et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6572542 | Houben et al. | Jun 2003 | B1 |
| 6574490 | Abbink et al. | Jun 2003 | B2 |
| 6576101 | Heller et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579690 | Bonnecaze et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6591125 | Buse et al. | Jul 2003 | B1 |
| 6592745 | Feldman et al. | Jul 2003 | B1 |
| 6595919 | Berner et al. | Jul 2003 | B2 |
| 6600997 | Deweese et al. | Jul 2003 | B2 |
| 6605200 | Mao et al. | Aug 2003 | B1 |
| 6605201 | Mao et al. | Aug 2003 | B1 |
| 6607509 | Bobroff et al. | Aug 2003 | B2 |
| 6610012 | Mault | Aug 2003 | B2 |
| 6616819 | Liamos et al. | Sep 2003 | B1 |
| 6618934 | Feldman et al. | Sep 2003 | B1 |
| 6622045 | Snell et al. | Sep 2003 | B2 |
| 6633772 | Ford et al. | Oct 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6641533 | Causey, III et al. | Nov 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6650471 | Doi | Nov 2003 | B2 |
| 6654625 | Say et al. | Nov 2003 | B1 |
| 6656114 | Poulson et al. | Dec 2003 | B1 |
| 6658396 | Tang et al. | Dec 2003 | B1 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6675030 | Ciuczak et al. | Jan 2004 | B2 |
| 6676816 | Mao et al. | Jan 2004 | B2 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6689056 | Kilcoyne et al. | Feb 2004 | B1 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6695860 | Ward et al. | Feb 2004 | B1 |
| 6698269 | Baber et al. | Mar 2004 | B2 |
| 6702857 | Brauker et al. | Mar 2004 | B2 |
| 6721582 | Trepagnier et al. | Apr 2004 | B2 |
| 6730200 | Stewart et al. | May 2004 | B1 |
| 6731985 | Poore et al. | May 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6736957 | Forrow et al. | May 2004 | B1 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6741877 | Shults et al. | May 2004 | B1 |
| 6746582 | Heller | Jun 2004 | B2 |
| 6749740 | Liamos et al. | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6764581 | Forrow et al. | Jul 2004 | B1 |
| 6770030 | Schaupp et al. | Aug 2004 | B1 |
| 6773671 | Lewis et al. | Aug 2004 | B1 |
| 6790178 | Mault et al. | Sep 2004 | B1 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6850790 | Berner et al. | Feb 2005 | B2 |
| 6862465 | Shults et al. | Mar 2005 | B2 |
| 6865407 | Kimball et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6881551 | Heller et al. | Apr 2005 | B2 |
| 6882940 | Potts et al. | Apr 2005 | B2 |
| 6892085 | McIvor et al. | May 2005 | B2 |
| 6893545 | Gotoh et al. | May 2005 | B2 |
| 6895263 | Shin et al. | May 2005 | B2 |
| 6895265 | Silver | May 2005 | B2 |
| 6912413 | Rantala et al. | Jun 2005 | B2 |
| 6923763 | Kovatchev et al. | Aug 2005 | B1 |
| 6931327 | Goode, Jr. et al. | Aug 2005 | B2 |
| 6932892 | Chen et al. | Aug 2005 | B2 |
| 6932894 | Mao et al. | Aug 2005 | B2 |
| 6936006 | Sabra | Aug 2005 | B2 |
| 6942518 | Liamos et al. | Sep 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6954662 | Freger et al. | Oct 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6968294 | Gutta et al. | Nov 2005 | B2 |
| 6971274 | Olin | Dec 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6990366 | Say et al. | Jan 2006 | B2 |
| 6997907 | Safabash et al. | Feb 2006 | B2 |
| 6998247 | Monfre et al. | Feb 2006 | B2 |
| 7003336 | Holker et al. | Feb 2006 | B2 |
| 7003340 | Say et al. | Feb 2006 | B2 |
| 7003341 | Say et al. | Feb 2006 | B2 |
| 7010345 | Hill et al. | Mar 2006 | B2 |
| 7011630 | Desai et al. | Mar 2006 | B2 |
| 7016713 | Gardner et al. | Mar 2006 | B2 |
| 7016720 | Kroll | Mar 2006 | B2 |
| 7022072 | Fox et al. | Apr 2006 | B2 |
| 7022219 | Mansouri et al. | Apr 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025425 | Kovatchev et al. | Apr 2006 | B2 |
| 7029443 | Kroll | Apr 2006 | B2 |
| 7029444 | Shin et al. | Apr 2006 | B2 |
| 7041068 | Freeman et al. | May 2006 | B2 |
| 7041468 | Drucker et al. | May 2006 | B2 |
| 7043287 | Khalil et al. | May 2006 | B1 |
| 7052472 | Miller et al. | May 2006 | B1 |
| 7052483 | Wojcik | May 2006 | B2 |
| 7056302 | Douglas | Jun 2006 | B2 |
| 7074307 | Simpson et al. | Jul 2006 | B2 |
| 7076300 | Kroll et al. | Jul 2006 | B1 |
| 7081195 | Simpson et al. | Jul 2006 | B2 |
| 7092891 | Maus et al. | Aug 2006 | B2 |
| 7096064 | Deno et al. | Aug 2006 | B2 |
| 7098803 | Mann et al. | Aug 2006 | B2 |
| 7103412 | Kroll | Sep 2006 | B1 |
| 7108778 | Simpson et al. | Sep 2006 | B2 |
| 7110803 | Shults et al. | Sep 2006 | B2 |
| 7113821 | Sun et al. | Sep 2006 | B1 |
| 7118667 | Lee | Oct 2006 | B2 |
| 7123950 | Mannheimer | Oct 2006 | B2 |
| 7134999 | Brauker et al. | Nov 2006 | B2 |
| 7136689 | Shults et al. | Nov 2006 | B2 |
| 7142911 | Boileau et al. | Nov 2006 | B2 |
| 7153265 | Vachon | Dec 2006 | B2 |
| 7167818 | Brown | Jan 2007 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7183102 | Monfre et al. | Feb 2007 | B2 |
| 7190988 | Say et al. | Mar 2007 | B2 |
| 7192450 | Brauker et al. | Mar 2007 | B2 |
| 7198606 | Boecker et al. | Apr 2007 | B2 |
| 7225535 | Feldman et al. | Jun 2007 | B2 |
| 7226978 | Tapsak et al. | Jun 2007 | B2 |
| 7258673 | Racchini et al. | Aug 2007 | B2 |
| 7267665 | Steil et al. | Sep 2007 | B2 |
| 7272436 | Gill et al. | Sep 2007 | B2 |
| 7276029 | Goode, Jr. et al. | Oct 2007 | B2 |
| 7278983 | Ireland et al. | Oct 2007 | B2 |
| 7295867 | Berner et al. | Nov 2007 | B2 |
| 7297114 | Gill et al. | Nov 2007 | B2 |
| 7299082 | Feldman et al. | Nov 2007 | B2 |
| 7310544 | Brister et al. | Dec 2007 | B2 |
| 7317938 | Lorenz et al. | Jan 2008 | B2 |
| 7335294 | Heller et al. | Feb 2008 | B2 |
| 7354420 | Steil et al. | Apr 2008 | B2 |
| 7364592 | Carr-Brendel et al. | Apr 2008 | B2 |
| 7366556 | Brister et al. | Apr 2008 | B2 |
| 7379765 | Petisce et al. | May 2008 | B2 |
| 7402153 | Steil et al. | Jul 2008 | B2 |
| 7404796 | Ginsberg | Jul 2008 | B2 |
| 7424318 | Brister et al. | Sep 2008 | B2 |
| 7460898 | Brister et al. | Dec 2008 | B2 |
| 7467003 | Brister et al. | Dec 2008 | B2 |
| 7468125 | Kraft et al. | Dec 2008 | B2 |
| 7471972 | Rhodes et al. | Dec 2008 | B2 |
| 7474992 | Ariyur | Jan 2009 | B2 |
| 7494465 | Brister et al. | Feb 2009 | B2 |
| 7497827 | Brister et al. | Mar 2009 | B2 |
| 7499002 | Blasko et al. | Mar 2009 | B2 |
| 7502644 | Gill et al. | Mar 2009 | B2 |
| 7519408 | Rasdal et al. | Apr 2009 | B2 |
| 7519478 | Bartkowiak et al. | Apr 2009 | B2 |
| 7523004 | Bartkowiak et al. | Apr 2009 | B2 |
| 7524287 | Bharmi | Apr 2009 | B2 |
| 7547281 | Hayes et al. | Jun 2009 | B2 |
| 7569030 | Lebel et al. | Aug 2009 | B2 |
| 7583990 | Goode, Jr. et al. | Sep 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7599726 | Goode, Jr. et al. | Oct 2009 | B2 |
| 7613491 | Boock et al. | Nov 2009 | B2 |
| 7615007 | Shults et al. | Nov 2009 | B2 |
| 7618369 | Hayter et al. | Nov 2009 | B2 |
| 7620438 | He | Nov 2009 | B2 |
| 7630748 | Budiman | Dec 2009 | B2 |
| 7632228 | Brauker et al. | Dec 2009 | B2 |
| 7635594 | Holmes et al. | Dec 2009 | B2 |
| 7637868 | Saint et al. | Dec 2009 | B2 |
| 7640048 | Dobbles et al. | Dec 2009 | B2 |
| 7699775 | Desai et al. | Apr 2010 | B2 |
| 7699964 | Feldman et al. | Apr 2010 | B2 |
| 7711493 | Bartkowiak et al. | May 2010 | B2 |
| 7736310 | Taub et al. | Jun 2010 | B2 |
| 7751864 | Buck, Jr. | Jul 2010 | B2 |
| 7766829 | Sloan et al. | Aug 2010 | B2 |
| 7771352 | Shults et al. | Aug 2010 | B2 |
| 7774145 | Bruaker et al. | Aug 2010 | B2 |
| 7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
| 7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
| 7857760 | Brister et al. | Dec 2010 | B2 |
| 7866026 | Wang et al. | Jan 2011 | B1 |
| 7885697 | Brister et al. | Feb 2011 | B2 |
| 7889069 | Fifolt et al. | Feb 2011 | B2 |
| 7899511 | Shults et al. | Mar 2011 | B2 |
| 7905833 | Brister et al. | Mar 2011 | B2 |
| 7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
| 7920906 | Goode et al. | Apr 2011 | B2 |
| 7938797 | Estes | May 2011 | B2 |
| 7946984 | Brister et al. | May 2011 | B2 |
| 7974672 | Shults et al. | Jul 2011 | B2 |
| 8060173 | Goode, Jr. et al. | Nov 2011 | B2 |
| 8116837 | Huang | Feb 2012 | B2 |
| 8140312 | Hayter et al. | Mar 2012 | B2 |
| 8160900 | Taub et al. | Apr 2012 | B2 |
| 8170803 | Kamath et al. | May 2012 | B2 |
| 8211016 | Budiman | Jul 2012 | B2 |
| 8216137 | Budiman | Jul 2012 | B2 |
| 8216138 | McGarraugh et al. | Jul 2012 | B1 |
| 8239166 | Hayter et al. | Aug 2012 | B2 |
| 8255026 | Al-Ali | Aug 2012 | B1 |
| 8282549 | Brauker et al. | Oct 2012 | B2 |
| 8376945 | Hayter et al. | Feb 2013 | B2 |
| 8444560 | Hayter et al. | May 2013 | B2 |
| 8457703 | Al-Ali | Jun 2013 | B2 |
| 8484005 | Hayter et al. | Jul 2013 | B2 |
| 8532935 | Budiman | Sep 2013 | B2 |
| 8543354 | Luo et al. | Sep 2013 | B2 |
| 8571808 | Hayter | Oct 2013 | B2 |
| 8612163 | Hayter et al. | Dec 2013 | B2 |
| 8657746 | Roy | Feb 2014 | B2 |
| 8682615 | Hayter et al. | Mar 2014 | B2 |
| 9060719 | Hayter et al. | Jun 2015 | B2 |
| 9113828 | Budiman | Aug 2015 | B2 |
| 9398872 | Hayter et al. | Jul 2016 | B2 |
| 9408566 | Hayter et al. | Aug 2016 | B2 |
| 9483608 | Hayter et al. | Nov 2016 | B2 |
| 9558325 | Hayter et al. | Jan 2017 | B2 |
| 20010041831 | Starkweather et al. | Nov 2001 | A1 |
| 20020016534 | Trepagnier et al. | Feb 2002 | A1 |
| 20020019022 | Dunn et al. | Feb 2002 | A1 |
| 20020042090 | Heller et al. | Apr 2002 | A1 |
| 20020065454 | Lebel et al. | May 2002 | A1 |
| 20020068860 | Clark | Jun 2002 | A1 |
| 20020103499 | Perez et al. | Aug 2002 | A1 |
| 20020106709 | Potts et al. | Aug 2002 | A1 |
| 20020120186 | Keimel | Aug 2002 | A1 |
| 20020128594 | Das et al. | Sep 2002 | A1 |
| 20020143266 | Bock | Oct 2002 | A1 |
| 20020143372 | Snell et al. | Oct 2002 | A1 |
| 20020156355 | Gough | Oct 2002 | A1 |
| 20020161288 | Shin et al. | Oct 2002 | A1 |
| 20020169635 | Shillingburg | Nov 2002 | A1 |
| 20020193679 | Malave et al. | Dec 2002 | A1 |
| 20030004403 | Drinan et al. | Jan 2003 | A1 |
| 20030023317 | Brauker et al. | Jan 2003 | A1 |
| 20030023461 | Quintanilla et al. | Jan 2003 | A1 |
| 20030032867 | Crothall et al. | Feb 2003 | A1 |
| 20030032874 | Rhodes et al. | Feb 2003 | A1 |
| 20030042137 | Mao et al. | Mar 2003 | A1 |
| 20030050546 | Desai et al. | Mar 2003 | A1 |
| 20030054428 | Monfre et al. | Mar 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030100821 | Heller et al. | May 2003 | A1 |
| 20030125612 | Fox et al. | Jul 2003 | A1 |
| 20030130616 | Steil et al. | Jul 2003 | A1 |
| 20030134347 | Heller et al. | Jul 2003 | A1 |
| 20030168338 | Gao et al. | Sep 2003 | A1 |
| 20030176933 | Lebel et al. | Sep 2003 | A1 |
| 20030187338 | Say et al. | Oct 2003 | A1 |
| 20030191377 | Robinson et al. | Oct 2003 | A1 |
| 20030199744 | Buse et al. | Oct 2003 | A1 |
| 20030199790 | Boecker et al. | Oct 2003 | A1 |
| 20030208113 | Mault et al. | Nov 2003 | A1 |
| 20030212317 | Kovatchev et al. | Nov 2003 | A1 |
| 20030212379 | Bylund et al. | Nov 2003 | A1 |
| 20030216630 | Jersey-Willuhn et al. | Nov 2003 | A1 |
| 20030217966 | Tapsak et al. | Nov 2003 | A1 |
| 20030235817 | Bartkowiak et al. | Dec 2003 | A1 |
| 20040010186 | Kimball et al. | Jan 2004 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040011671 | Shults et al. | Jan 2004 | A1 |
| 20040024553 | Monfre et al. | Feb 2004 | A1 |
| 20040039298 | Abreu | Feb 2004 | A1 |
| 20040040840 | Mao et al. | Mar 2004 | A1 |
| 20040045879 | Shults et al. | Mar 2004 | A1 |
| 20040054263 | Moerman et al. | Mar 2004 | A1 |
| 20040064068 | DeNuzzio et al. | Apr 2004 | A1 |
| 20040077962 | Kroll | Apr 2004 | A1 |
| 20040078065 | Kroll | Apr 2004 | A1 |
| 20040093167 | Braig et al. | May 2004 | A1 |
| 20040099529 | Mao et al. | May 2004 | A1 |
| 20040106858 | Say et al. | Jun 2004 | A1 |
| 20040122353 | Shahmirian et al. | Jun 2004 | A1 |
| 20040133164 | Funderburk et al. | Jul 2004 | A1 |
| 20040135684 | Steinthal et al. | Jul 2004 | A1 |
| 20040138588 | Saikley et al. | Jul 2004 | A1 |
| 20040138716 | Kon et al. | Jul 2004 | A1 |
| 20040142403 | Hetzel et al. | Jul 2004 | A1 |
| 20040146909 | Duong et al. | Jul 2004 | A1 |
| 20040152622 | Keith et al. | Aug 2004 | A1 |
| 20040162678 | Hetzel et al. | Aug 2004 | A1 |
| 20040167801 | Say et al. | Aug 2004 | A1 |
| 20040171921 | Say et al. | Sep 2004 | A1 |
| 20040172307 | Gruber | Sep 2004 | A1 |
| 20040176672 | Silver et al. | Sep 2004 | A1 |
| 20040186362 | Brauker et al. | Sep 2004 | A1 |
| 20040186365 | Jin et al. | Sep 2004 | A1 |
| 20040193025 | Steil et al. | Sep 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20040197846 | Hockersmith et al. | Oct 2004 | A1 |
| 20040199059 | Brauker et al. | Oct 2004 | A1 |
| 20040204687 | Mogensen et al. | Oct 2004 | A1 |
| 20040208780 | Faries, Jr. et al. | Oct 2004 | A1 |
| 20040225338 | Lebel et al. | Nov 2004 | A1 |
| 20040236200 | Say et al. | Nov 2004 | A1 |
| 20040249253 | Racchini et al. | Dec 2004 | A1 |
| 20040249420 | Olson et al. | Dec 2004 | A1 |
| 20040254433 | Bandis et al. | Dec 2004 | A1 |
| 20040254434 | Goodnow et al. | Dec 2004 | A1 |
| 20040260478 | Schwamm | Dec 2004 | A1 |
| 20040263354 | Mann et al. | Dec 2004 | A1 |
| 20040267300 | Mace | Dec 2004 | A1 |
| 20050003470 | Nelson et al. | Jan 2005 | A1 |
| 20050004439 | Shin et al. | Jan 2005 | A1 |
| 20050004494 | Perez et al. | Jan 2005 | A1 |
| 20050010087 | Banet et al. | Jan 2005 | A1 |
| 20050010269 | Lebel et al. | Jan 2005 | A1 |
| 20050016276 | Guan et al. | Jan 2005 | A1 |
| 20050027177 | Shin et al. | Feb 2005 | A1 |
| 20050027180 | Goode et al. | Feb 2005 | A1 |
| 20050027181 | Goode et al. | Feb 2005 | A1 |
| 20050027462 | Goode et al. | Feb 2005 | A1 |
| 20050027463 | Goode et al. | Feb 2005 | A1 |
| 20050031689 | Shults et al. | Feb 2005 | A1 |
| 20050038332 | Saidara et al. | Feb 2005 | A1 |
| 20050043598 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050049179 | Davidson et al. | Mar 2005 | A1 |
| 20050049473 | Desai et al. | Mar 2005 | A1 |
| 20050070774 | Addison et al. | Mar 2005 | A1 |
| 20050090607 | Tapsak et al. | Apr 2005 | A1 |
| 20050096511 | Fox et al. | May 2005 | A1 |
| 20050096512 | Fox et al. | May 2005 | A1 |
| 20050112169 | Brauker et al. | May 2005 | A1 |
| 20050113653 | Fox et al. | May 2005 | A1 |
| 20050114068 | Chey et al. | May 2005 | A1 |
| 20050115832 | Simpson et al. | Jun 2005 | A1 |
| 20050121322 | Say et al. | Jun 2005 | A1 |
| 20050131346 | Douglas | Jun 2005 | A1 |
| 20050143635 | Kamath et al. | Jun 2005 | A1 |
| 20050154271 | Rasdal et al. | Jul 2005 | A1 |
| 20050176136 | Burd et al. | Aug 2005 | A1 |
| 20050177398 | Watanabe et al. | Aug 2005 | A1 |
| 20050182306 | Sloan | Aug 2005 | A1 |
| 20050187720 | Goode, Jr. et al. | Aug 2005 | A1 |
| 20050192494 | Ginsberg | Sep 2005 | A1 |
| 20050192557 | Brauker et al. | Sep 2005 | A1 |
| 20050195930 | Spital et al. | Sep 2005 | A1 |
| 20050196821 | Monfre et al. | Sep 2005 | A1 |
| 20050199494 | Say et al. | Sep 2005 | A1 |
| 20050203360 | Brauker et al. | Sep 2005 | A1 |
| 20050214892 | Kovatchev et al. | Sep 2005 | A1 |
| 20050239154 | Feldman et al. | Oct 2005 | A1 |
| 20050239156 | Drucker et al. | Oct 2005 | A1 |
| 20050241957 | Mao et al. | Nov 2005 | A1 |
| 20050245795 | Goode, Jr. et al. | Nov 2005 | A1 |
| 20050245799 | Brauker et al. | Nov 2005 | A1 |
| 20050245839 | Stivoric et al. | Nov 2005 | A1 |
| 20050245904 | Estes et al. | Nov 2005 | A1 |
| 20050277164 | Drucker et al. | Dec 2005 | A1 |
| 20050277912 | John | Dec 2005 | A1 |
| 20050287620 | Heller et al. | Dec 2005 | A1 |
| 20050288725 | Hettrick et al. | Dec 2005 | A1 |
| 20060001538 | Kraft et al. | Jan 2006 | A1 |
| 20060004270 | Bedard et al. | Jan 2006 | A1 |
| 20060010098 | Goodnow et al. | Jan 2006 | A1 |
| 20060015020 | Neale et al. | Jan 2006 | A1 |
| 20060015024 | Brister et al. | Jan 2006 | A1 |
| 20060016700 | Brister et al. | Jan 2006 | A1 |
| 20060017923 | Ruchti et al. | Jan 2006 | A1 |
| 20060019327 | Brister et al. | Jan 2006 | A1 |
| 20060020186 | Brister et al. | Jan 2006 | A1 |
| 20060020187 | Brister et al. | Jan 2006 | A1 |
| 20060020188 | Kamath et al. | Jan 2006 | A1 |
| 20060020189 | Brister et al. | Jan 2006 | A1 |
| 20060020190 | Kamath et al. | Jan 2006 | A1 |
| 20060020191 | Brister et al. | Jan 2006 | A1 |
| 20060020192 | Brister et al. | Jan 2006 | A1 |
| 20060025662 | Buse et al. | Feb 2006 | A1 |
| 20060025663 | Talbot et al. | Feb 2006 | A1 |
| 20060029177 | Cranford, Jr. et al. | Feb 2006 | A1 |
| 20060031094 | Cohen et al. | Feb 2006 | A1 |
| 20060036139 | Brister et al. | Feb 2006 | A1 |
| 20060036140 | Brister et al. | Feb 2006 | A1 |
| 20060036141 | Kamath et al. | Feb 2006 | A1 |
| 20060036142 | Brister et al. | Feb 2006 | A1 |
| 20060036143 | Brister et al. | Feb 2006 | A1 |
| 20060036144 | Brister et al. | Feb 2006 | A1 |
| 20060036145 | Brister et al. | Feb 2006 | A1 |
| 20060091006 | Wang et al. | May 2006 | A1 |
| 20060142651 | Brister et al. | Jun 2006 | A1 |
| 20060155180 | Brister et al. | Jul 2006 | A1 |
| 20060166629 | Reggiardo | Jul 2006 | A1 |
| 20060167365 | Bharmi | Jul 2006 | A1 |
| 20060167517 | Gill et al. | Jul 2006 | A1 |
| 20060167518 | Gill et al. | Jul 2006 | A1 |
| 20060167519 | Gill et al. | Jul 2006 | A1 |
| 20060173260 | Gaoni et al. | Aug 2006 | A1 |
| 20060173406 | Hayes et al. | Aug 2006 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060183984 | Dobbles et al. | Aug 2006 | A1 |
| 20060183985 | Brister et al. | Aug 2006 | A1 |
| 20060189851 | Tvig et al. | Aug 2006 | A1 |
| 20060189863 | Peyser et al. | Aug 2006 | A1 |
| 20060193375 | Lee | Aug 2006 | A1 |
| 20060222566 | Brauker et al. | Oct 2006 | A1 |
| 20060224109 | Steil et al. | Oct 2006 | A1 |
| 20060226985 | Goodnow et al. | Oct 2006 | A1 |
| 20060229512 | Petisce et al. | Oct 2006 | A1 |
| 20060247508 | Fennell | Nov 2006 | A1 |
| 20060247685 | Bharmi | Nov 2006 | A1 |
| 20060247985 | Liamos et al. | Nov 2006 | A1 |
| 20060258929 | Goode et al. | Nov 2006 | A1 |
| 20060264785 | Dring et al. | Nov 2006 | A1 |
| 20060272652 | Stocker et al. | Dec 2006 | A1 |
| 20060281985 | Ward et al. | Dec 2006 | A1 |
| 20070016381 | Kamath et al. | Jan 2007 | A1 |
| 20070027381 | Stafford | Feb 2007 | A1 |
| 20070032706 | Kamath et al. | Feb 2007 | A1 |
| 20070033074 | Nitzan et al. | Feb 2007 | A1 |
| 20070056858 | Chen et al. | Mar 2007 | A1 |
| 20070060803 | Liljeryd et al. | Mar 2007 | A1 |
| 20070060814 | Stafford | Mar 2007 | A1 |
| 20070066873 | Kamath et al. | Mar 2007 | A1 |
| 20070068807 | Feldman et al. | Mar 2007 | A1 |
| 20070071681 | Gadkar et al. | Mar 2007 | A1 |
| 20070073129 | Shah et al. | Mar 2007 | A1 |
| 20070078320 | Stafford | Apr 2007 | A1 |
| 20070078321 | Mazza et al. | Apr 2007 | A1 |
| 20070078322 | Stafford | Apr 2007 | A1 |
| 20070078323 | Reggiardo et al. | Apr 2007 | A1 |
| 20070095661 | Wang et al. | May 2007 | A1 |
| 20070106135 | Sloan et al. | May 2007 | A1 |
| 20070108048 | Wang et al. | May 2007 | A1 |
| 20070118030 | Bruce et al. | May 2007 | A1 |
| 20070118405 | Campbell et al. | May 2007 | A1 |
| 20070124002 | Estes et al. | May 2007 | A1 |
| 20070129621 | Kellogg et al. | Jun 2007 | A1 |
| 20070149873 | Say et al. | Jun 2007 | A1 |
| 20070149875 | Ouyang et al. | Jun 2007 | A1 |
| 20070156033 | Causey, III et al. | Jul 2007 | A1 |
| 20070163880 | Woo et al. | Jul 2007 | A1 |
| 20070168224 | Letzt et al. | Jul 2007 | A1 |
| 20070173706 | Neinast et al. | Jul 2007 | A1 |
| 20070173709 | Petisce et al. | Jul 2007 | A1 |
| 20070173710 | Petisce et al. | Jul 2007 | A1 |
| 20070173761 | Kanderian et al. | Jul 2007 | A1 |
| 20070179349 | Hoyme et al. | Aug 2007 | A1 |
| 20070179352 | Randlov et al. | Aug 2007 | A1 |
| 20070179434 | Weinert et al. | Aug 2007 | A1 |
| 20070191701 | Feldman et al. | Aug 2007 | A1 |
| 20070199818 | Petyt et al. | Aug 2007 | A1 |
| 20070202562 | Curry et al. | Aug 2007 | A1 |
| 20070203407 | Hoss et al. | Aug 2007 | A1 |
| 20070203966 | Brauker et al. | Aug 2007 | A1 |
| 20070213657 | Jennewine et al. | Sep 2007 | A1 |
| 20070227911 | Wang et al. | Oct 2007 | A1 |
| 20070232877 | He | Oct 2007 | A1 |
| 20070232878 | Kovatchev et al. | Oct 2007 | A1 |
| 20070232880 | Siddiqui et al. | Oct 2007 | A1 |
| 20070233013 | Schoenberg et al. | Oct 2007 | A1 |
| 20070235331 | Simpson et al. | Oct 2007 | A1 |
| 20070249922 | Peyser et al. | Oct 2007 | A1 |
| 20070255321 | Gerber et al. | Nov 2007 | A1 |
| 20070282299 | Hellwig | Dec 2007 | A1 |
| 20070299617 | Willis | Dec 2007 | A1 |
| 20080004515 | Jennewine et al. | Jan 2008 | A1 |
| 20080004601 | Jennewine et al. | Jan 2008 | A1 |
| 20080009692 | Stafford | Jan 2008 | A1 |
| 20080012701 | Kass et al. | Jan 2008 | A1 |
| 20080017522 | Heller et al. | Jan 2008 | A1 |
| 20080021666 | Goode, Jr. et al. | Jan 2008 | A1 |
| 20080021972 | Huelskamp et al. | Jan 2008 | A1 |
| 20080029391 | Mao et al. | Feb 2008 | A1 |
| 20080033254 | Kamath et al. | Feb 2008 | A1 |
| 20080039702 | Hayter et al. | Feb 2008 | A1 |
| 20080045824 | Tapsak et al. | Feb 2008 | A1 |
| 20080058625 | McGarraugh et al. | Mar 2008 | A1 |
| 20080064937 | McGarraugh et al. | Mar 2008 | A1 |
| 20080066305 | Wang et al. | Mar 2008 | A1 |
| 20080071156 | Brister et al. | Mar 2008 | A1 |
| 20080071157 | McGarraugh et al. | Mar 2008 | A1 |
| 20080071158 | McGarraugh et al. | Mar 2008 | A1 |
| 20080081977 | Hayter et al. | Apr 2008 | A1 |
| 20080083617 | Simpson et al. | Apr 2008 | A1 |
| 20080086042 | Brister et al. | Apr 2008 | A1 |
| 20080086044 | Brister et al. | Apr 2008 | A1 |
| 20080086273 | Shults et al. | Apr 2008 | A1 |
| 20080097289 | Steil et al. | Apr 2008 | A1 |
| 20080102441 | Chen et al. | May 2008 | A1 |
| 20080108942 | Brister et al. | May 2008 | A1 |
| 20080119703 | Brister et al. | May 2008 | A1 |
| 20080119708 | Budiman | May 2008 | A1 |
| 20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
| 20080148873 | Wang | Jun 2008 | A1 |
| 20080154513 | Kovatchev et al. | Jun 2008 | A1 |
| 20080161666 | Feldman et al. | Jul 2008 | A1 |
| 20080167543 | Say et al. | Jul 2008 | A1 |
| 20080172205 | Breton et al. | Jul 2008 | A1 |
| 20080177149 | Weinert et al. | Jul 2008 | A1 |
| 20080177165 | Blomquist et al. | Jul 2008 | A1 |
| 20080179187 | Ouyang et al. | Jul 2008 | A1 |
| 20080183060 | Steil et al. | Jul 2008 | A1 |
| 20080183061 | Goode et al. | Jul 2008 | A1 |
| 20080183399 | Goode et al. | Jul 2008 | A1 |
| 20080188731 | Brister et al. | Aug 2008 | A1 |
| 20080188796 | Steil et al. | Aug 2008 | A1 |
| 20080189051 | Goode et al. | Aug 2008 | A1 |
| 20080194934 | Ray et al. | Aug 2008 | A1 |
| 20080194935 | Brister et al. | Aug 2008 | A1 |
| 20080194936 | Goode et al. | Aug 2008 | A1 |
| 20080194937 | Goode et al. | Aug 2008 | A1 |
| 20080194938 | Brister et al. | Aug 2008 | A1 |
| 20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
| 20080195967 | Goode et al. | Aug 2008 | A1 |
| 20080197024 | Simpson et al. | Aug 2008 | A1 |
| 20080200788 | Brister et al. | Aug 2008 | A1 |
| 20080200789 | Brister et al. | Aug 2008 | A1 |
| 20080200791 | Simpson et al. | Aug 2008 | A1 |
| 20080201325 | Doniger et al. | Aug 2008 | A1 |
| 20080208025 | Shults et al. | Aug 2008 | A1 |
| 20080208113 | Damiano et al. | Aug 2008 | A1 |
| 20080214910 | Buck | Sep 2008 | A1 |
| 20080214915 | Brister et al. | Sep 2008 | A1 |
| 20080214918 | Brister et al. | Sep 2008 | A1 |
| 20080228051 | Shults et al. | Sep 2008 | A1 |
| 20080228054 | Shults et al. | Sep 2008 | A1 |
| 20080234943 | Ray et al. | Sep 2008 | A1 |
| 20080242961 | Brister et al. | Oct 2008 | A1 |
| 20080242963 | Essenpreis et al. | Oct 2008 | A1 |
| 20080255434 | Hayter et al. | Oct 2008 | A1 |
| 20080255437 | Hayter | Oct 2008 | A1 |
| 20080255438 | Saidara et al. | Oct 2008 | A1 |
| 20080255808 | Hayter | Oct 2008 | A1 |
| 20080256048 | Hayter | Oct 2008 | A1 |
| 20080262469 | Brister et al. | Oct 2008 | A1 |
| 20080267823 | Wang et al. | Oct 2008 | A1 |
| 20080275313 | Brister et al. | Nov 2008 | A1 |
| 20080278332 | Fennel et al. | Nov 2008 | A1 |
| 20080287761 | Hayter | Nov 2008 | A1 |
| 20080287762 | Hayter | Nov 2008 | A1 |
| 20080287763 | Hayter | Nov 2008 | A1 |
| 20080287764 | Rasdal et al. | Nov 2008 | A1 |
| 20080287765 | Rasdal et al. | Nov 2008 | A1 |
| 20080287766 | Rasdal et al. | Nov 2008 | A1 |
| 20080288180 | Hayter | Nov 2008 | A1 |
| 20080288204 | Hayter et al. | Nov 2008 | A1 |
| 20080296155 | Shults et al. | Dec 2008 | A1 |
| 20080300572 | Rankers et al. | Dec 2008 | A1 |
| 20080306368 | Goode et al. | Dec 2008 | A1 |
| 20080306434 | Dobbles et al. | Dec 2008 | A1 |
| 20080306435 | Kamath et al. | Dec 2008 | A1 |
| 20080306444 | Brister et al. | Dec 2008 | A1 |
| 20080312841 | Hayter | Dec 2008 | A1 |
| 20080312842 | Hayter | Dec 2008 | A1 |
| 20080312844 | Hayter et al. | Dec 2008 | A1 |
| 20080312845 | Hayter et al. | Dec 2008 | A1 |
| 20080314395 | Kovatchev et al. | Dec 2008 | A1 |
| 20080319279 | Ramsay et al. | Dec 2008 | A1 |
| 20080319295 | Bernstein et al. | Dec 2008 | A1 |
| 20080319296 | Bernstein et al. | Dec 2008 | A1 |
| 20090005665 | Hayter et al. | Jan 2009 | A1 |
| 20090005666 | Shin et al. | Jan 2009 | A1 |
| 20090006034 | Hayter et al. | Jan 2009 | A1 |
| 20090006061 | Thukral et al. | Jan 2009 | A1 |
| 20090006133 | Weinert et al. | Jan 2009 | A1 |
| 20090012376 | Agus | Jan 2009 | A1 |
| 20090012379 | Goode et al. | Jan 2009 | A1 |
| 20090018424 | Kamath et al. | Jan 2009 | A1 |
| 20090018425 | Ouyang et al. | Jan 2009 | A1 |
| 20090030293 | Cooper et al. | Jan 2009 | A1 |
| 20090030294 | Petisce et al. | Jan 2009 | A1 |
| 20090033482 | Hayter et al. | Feb 2009 | A1 |
| 20090036747 | Hayter et al. | Feb 2009 | A1 |
| 20090036758 | Brauker et al. | Feb 2009 | A1 |
| 20090036760 | Hayter | Feb 2009 | A1 |
| 20090036763 | Brauker et al. | Feb 2009 | A1 |
| 20090043181 | Brauker et al. | Feb 2009 | A1 |
| 20090043182 | Brauker et al. | Feb 2009 | A1 |
| 20090043525 | Brauker et al. | Feb 2009 | A1 |
| 20090043541 | Brauker et al. | Feb 2009 | A1 |
| 20090043542 | Brauker et al. | Feb 2009 | A1 |
| 20090045055 | Rhodes et al. | Feb 2009 | A1 |
| 20090048503 | Dalal et al. | Feb 2009 | A1 |
| 20090054745 | Jennewine et al. | Feb 2009 | A1 |
| 20090054748 | Feldman et al. | Feb 2009 | A1 |
| 20090054749 | He | Feb 2009 | A1 |
| 20090054753 | Robinson et al. | Feb 2009 | A1 |
| 20090055149 | Hayter et al. | Feb 2009 | A1 |
| 20090062633 | Brauker et al. | Mar 2009 | A1 |
| 20090062635 | Brauker et al. | Mar 2009 | A1 |
| 20090062767 | VanAntwerp et al. | Mar 2009 | A1 |
| 20090063402 | Hayter | Mar 2009 | A1 |
| 20090069649 | Budiman | Mar 2009 | A1 |
| 20090076356 | Simpson et al. | Mar 2009 | A1 |
| 20090076360 | Brister et al. | Mar 2009 | A1 |
| 20090076361 | Kamath et al. | Mar 2009 | A1 |
| 20090082693 | Stafford | Mar 2009 | A1 |
| 20090085768 | Patel et al. | Apr 2009 | A1 |
| 20090099436 | Brister et al. | Apr 2009 | A1 |
| 20090105560 | Solomon | Apr 2009 | A1 |
| 20090105570 | Sloan et al. | Apr 2009 | A1 |
| 20090105636 | Hayter et al. | Apr 2009 | A1 |
| 20090112478 | Mueller, Jr. et al. | Apr 2009 | A1 |
| 20090112626 | Talbot et al. | Apr 2009 | A1 |
| 20090118589 | Ueshima et al. | May 2009 | A1 |
| 20090124877 | Goode, Jr. et al. | May 2009 | A1 |
| 20090124878 | Goode et al. | May 2009 | A1 |
| 20090124879 | Brister et al. | May 2009 | A1 |
| 20090124964 | Leach et al. | May 2009 | A1 |
| 20090131768 | Simpson et al. | May 2009 | A1 |
| 20090131769 | Leach et al. | May 2009 | A1 |
| 20090131776 | Simpson et al. | May 2009 | A1 |
| 20090131777 | Simpson et al. | May 2009 | A1 |
| 20090137886 | Shariati et al. | May 2009 | A1 |
| 20090137887 | Shariati et al. | May 2009 | A1 |
| 20090143659 | Li et al. | Jun 2009 | A1 |
| 20090143660 | Brister et al. | Jun 2009 | A1 |
| 20090143725 | Peyser et al. | Jun 2009 | A1 |
| 20090149728 | Van Antwerp et al. | Jun 2009 | A1 |
| 20090156919 | Brister et al. | Jun 2009 | A1 |
| 20090156924 | Shariati et al. | Jun 2009 | A1 |
| 20090163790 | Brister et al. | Jun 2009 | A1 |
| 20090163791 | Brister et al. | Jun 2009 | A1 |
| 20090163855 | Shin et al. | Jun 2009 | A1 |
| 20090164190 | Hayter | Jun 2009 | A1 |
| 20090164239 | Hayter et al. | Jun 2009 | A1 |
| 20090164251 | Hayter | Jun 2009 | A1 |
| 20090178459 | Li et al. | Jul 2009 | A1 |
| 20090182217 | Li et al. | Jul 2009 | A1 |
| 20090182517 | Gandhi et al. | Jul 2009 | A1 |
| 20090192366 | Mensinger et al. | Jul 2009 | A1 |
| 20090192380 | Shariati et al. | Jul 2009 | A1 |
| 20090192722 | Shariati et al. | Jul 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090192745 | Kamath et al. | Jul 2009 | A1 |
| 20090192751 | Kamath et al. | Jul 2009 | A1 |
| 20090198118 | Hayter et al. | Aug 2009 | A1 |
| 20090203981 | Brauker et al. | Aug 2009 | A1 |
| 20090204341 | Brauker et al. | Aug 2009 | A1 |
| 20090216103 | Brister et al. | Aug 2009 | A1 |
| 20090240120 | Mensinger et al. | Sep 2009 | A1 |
| 20090240128 | Mensinger et al. | Sep 2009 | A1 |
| 20090240193 | Mensinger et al. | Sep 2009 | A1 |
| 20090242399 | Kamath et al. | Oct 2009 | A1 |
| 20090242425 | Kamath et al. | Oct 2009 | A1 |
| 20090247855 | Boock et al. | Oct 2009 | A1 |
| 20090247856 | Boock et al. | Oct 2009 | A1 |
| 20090247857 | Harper et al. | Oct 2009 | A1 |
| 20090253973 | Bashan et al. | Oct 2009 | A1 |
| 20090257911 | Thomas et al. | Oct 2009 | A1 |
| 20090281406 | McGarraugh et al. | Nov 2009 | A1 |
| 20090281407 | Budiman | Nov 2009 | A1 |
| 20090287073 | Boock et al. | Nov 2009 | A1 |
| 20090287074 | Shults et al. | Nov 2009 | A1 |
| 20090294277 | Thomas et al. | Dec 2009 | A1 |
| 20090299155 | Yang et al. | Dec 2009 | A1 |
| 20090299156 | Simpson et al. | Dec 2009 | A1 |
| 20090299162 | Brauker et al. | Dec 2009 | A1 |
| 20090299276 | Brauker et al. | Dec 2009 | A1 |
| 20100010324 | Brauker et al. | Jan 2010 | A1 |
| 20100010331 | Brauker et al. | Jan 2010 | A1 |
| 20100010332 | Brauker et al. | Jan 2010 | A1 |
| 20100057040 | Hayter | Mar 2010 | A1 |
| 20100057041 | Hayter | Mar 2010 | A1 |
| 20100057042 | Hayter | Mar 2010 | A1 |
| 20100057044 | Hayter | Mar 2010 | A1 |
| 20100057057 | Hayter et al. | Mar 2010 | A1 |
| 20100063372 | Potts et al. | Mar 2010 | A1 |
| 20100064764 | Hayter et al. | Mar 2010 | A1 |
| 20100081906 | Hayter et al. | Apr 2010 | A1 |
| 20100081909 | Budiman | Apr 2010 | A1 |
| 20100081953 | Syeda-Mahmood et al. | Apr 2010 | A1 |
| 20100121167 | McGarraugh et al. | May 2010 | A1 |
| 20100141656 | Krieftewirth | Jun 2010 | A1 |
| 20100152561 | Goodnow et al. | Jun 2010 | A1 |
| 20100160759 | Celentano et al. | Jun 2010 | A1 |
| 20100168538 | Keenan et al. | Jul 2010 | A1 |
| 20100168546 | Kamath et al. | Jul 2010 | A1 |
| 20100174266 | Estes | Jul 2010 | A1 |
| 20100191085 | Budiman | Jul 2010 | A1 |
| 20100191472 | Doniger et al. | Jul 2010 | A1 |
| 20100198034 | Thomas et al. | Aug 2010 | A1 |
| 20100198142 | Sloan et al. | Aug 2010 | A1 |
| 20100204557 | Kiaie et al. | Aug 2010 | A1 |
| 20100213057 | Feldman et al. | Aug 2010 | A1 |
| 20100230285 | Hoss et al. | Sep 2010 | A1 |
| 20100234710 | Budiman et al. | Sep 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100265073 | Harper et al. | Oct 2010 | A1 |
| 20100274515 | Hoss | Oct 2010 | A1 |
| 20100277342 | Sicurello et al. | Nov 2010 | A1 |
| 20100280441 | Willinska et al. | Nov 2010 | A1 |
| 20100280782 | Harper et al. | Nov 2010 | A1 |
| 20100312176 | Lauer et al. | Dec 2010 | A1 |
| 20100313105 | Nekoomaram et al. | Dec 2010 | A1 |
| 20100317952 | Budiman et al. | Dec 2010 | A1 |
| 20100324392 | Yee et al. | Dec 2010 | A1 |
| 20100326842 | Mazza et al. | Dec 2010 | A1 |
| 20110021889 | Hoss et al. | Jan 2011 | A1 |
| 20110024043 | Boock et al. | Feb 2011 | A1 |
| 20110024307 | Simpson et al. | Feb 2011 | A1 |
| 20110027127 | Simpson et al. | Feb 2011 | A1 |
| 20110027453 | Boock et al. | Feb 2011 | A1 |
| 20110027458 | Boock et al. | Feb 2011 | A1 |
| 20110028815 | Simpson et al. | Feb 2011 | A1 |
| 20110028816 | Simpson et al. | Feb 2011 | A1 |
| 20110029247 | Kalathil | Feb 2011 | A1 |
| 20110040163 | Telson et al. | Feb 2011 | A1 |
| 20110060530 | Fennell | Mar 2011 | A1 |
| 20110077490 | Simpson et al. | Mar 2011 | A1 |
| 20110077494 | Doniger et al. | Mar 2011 | A1 |
| 20110081726 | Berman et al. | Apr 2011 | A1 |
| 20110082484 | Saravia et al. | Apr 2011 | A1 |
| 20110105873 | Feldman et al. | May 2011 | A1 |
| 20110106126 | Love et al. | May 2011 | A1 |
| 20110112696 | Yodfat et al. | May 2011 | A1 |
| 20110148905 | Simmons et al. | Jun 2011 | A1 |
| 20110184268 | Taub | Jul 2011 | A1 |
| 20110190603 | Stafford | Aug 2011 | A1 |
| 20110191044 | Stafford | Aug 2011 | A1 |
| 20110193704 | Harper et al. | Aug 2011 | A1 |
| 20110208027 | Wagner et al. | Aug 2011 | A1 |
| 20110208155 | Palerm et al. | Aug 2011 | A1 |
| 20110213225 | Bernstein et al. | Sep 2011 | A1 |
| 20110224523 | Budiman | Sep 2011 | A1 |
| 20110257495 | Hoss et al. | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20110263958 | Brauker et al. | Oct 2011 | A1 |
| 20110288574 | Curry et al. | Nov 2011 | A1 |
| 20110319729 | Donnay et al. | Dec 2011 | A1 |
| 20110320130 | Valdes et al. | Dec 2011 | A1 |
| 20110320167 | Budiman | Dec 2011 | A1 |
| 20120010642 | Lee et al. | Jan 2012 | A1 |
| 20120078071 | Bohm et al. | Mar 2012 | A1 |
| 20120108931 | Taub | May 2012 | A1 |
| 20120108934 | Valdes et al. | May 2012 | A1 |
| 20120165626 | Irina et al. | Jun 2012 | A1 |
| 20120165640 | Galley et al. | Jun 2012 | A1 |
| 20120173200 | Breton et al. | Jul 2012 | A1 |
| 20120209099 | Ljuhs et al. | Aug 2012 | A1 |
| 20120215462 | Goode et al. | Aug 2012 | A1 |
| 20120245447 | Karan et al. | Sep 2012 | A1 |
| 20120277565 | Budiman | Nov 2012 | A1 |
| 20120283542 | McGarraugh | Nov 2012 | A1 |
| 20120318670 | Karinka et al. | Dec 2012 | A1 |
| 20130035575 | Mayou et al. | Feb 2013 | A1 |
| 20130137953 | Harper et al. | May 2013 | A1 |
| 20130184547 | Taub et al. | Jul 2013 | A1 |
| 20130231541 | Hayter et al. | Sep 2013 | A1 |
| 20130324823 | Koski et al. | Dec 2013 | A1 |
| 20140005499 | Catt et al. | Jan 2014 | A1 |
| 20140046160 | Terashima et al. | Feb 2014 | A1 |
| 20140088392 | Bernstein et al. | Mar 2014 | A1 |
| 20140121480 | Budiman et al. | May 2014 | A1 |
| 20140121488 | Budiman | May 2014 | A1 |
| 20140221966 | Buckingham et al. | Aug 2014 | A1 |
| 20150216456 | Budiman | Aug 2015 | A1 |
| 20150241407 | Ou et al. | Aug 2015 | A1 |
| 20150366510 | Budiman | Dec 2015 | A1 |
| 20160022221 | Ou et al. | Jan 2016 | A1 |
| 20160302701 | Bhavaraju et al. | Oct 2016 | A1 |
| Number | Date | Country |
|---|---|---|
| 0098592 | Jan 1984 | EP |
| 0127958 | Dec 1984 | EP |
| 0320109 | Jun 1989 | EP |
| 0353328 | Feb 1990 | EP |
| 0390390 | Oct 1990 | EP |
| 0396788 | Nov 1990 | EP |
| 0472411 | Feb 1992 | EP |
| 0286118 | Jan 1995 | EP |
| 0867146 | Sep 1998 | EP |
| 1048264 | Nov 2000 | EP |
| 1419731 | May 2004 | EP |
| 0939602 | Sep 2004 | EP |
| 1850909 | Apr 2010 | EP |
| 1677668 | Jul 2010 | EP |
| 2004-358261 | Dec 2004 | JP |
| WO-1996025089 | Aug 1996 | WO |
| WO-1996035370 | Nov 1996 | WO |
| WO-1997015227 | May 1997 | WO |
| WO-1998035053 | Aug 1998 | WO |
| WO-1999056613 | Nov 1999 | WO |
| WO-2000049940 | Aug 2000 | WO |
| WO-2000059370 | Oct 2000 | WO |
| WO-2000074753 | Dec 2000 | WO |
| WO-2000078992 | Dec 2000 | WO |
| WO-2001052935 | Jul 2001 | WO |
| WO-2001054753 | Aug 2001 | WO |
| WO-2002016905 | Feb 2002 | WO |
| WO-2002058537 | Aug 2002 | WO |
| WO-2003076893 | Sep 2003 | WO |
| WO-2003082091 | Oct 2003 | WO |
| WO-2003085372 | Oct 2003 | WO |
| WO-2004060455 | Jul 2004 | WO |
| WO-2004061420 | Jul 2004 | WO |
| WO-2005010756 | Feb 2005 | WO |
| WO-2005041766 | May 2005 | WO |
| WO-2005065542 | Jul 2005 | WO |
| WO-2005089103 | Sep 2005 | WO |
| WO-2006024671 | Mar 2006 | WO |
| WO-2006079114 | Jul 2006 | WO |
| WO-2006081336 | Aug 2006 | WO |
| WO-2006085087 | Aug 2006 | WO |
| WO-2006086423 | Aug 2006 | WO |
| WO-2007097754 | Aug 2007 | WO |
| WO-2008001366 | Jan 2008 | WO |
| WO-2008086541 | Jul 2008 | WO |
| Entry |
|---|
| TheraSense Freestyle Tracker User's Guide, ART01694 Rev. B, 2002 (Year: 2002). |
| Alemzadeh, R, “Sensor-Augmented Insulin Pump Therapy: Clinical Applications”, Medical College of Wisconsin Diabetes Symposium, pp. 1-61, 2011. |
| Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526. |
| Arnold, M. A., et al., “Selectivity Assessment of Noninvasive Glucose Measurements Based on Analysis of Multivariate Calibration Vectors”, Journal of Diabetes Science and Technology, vol. 1, No. 4, 2007, pp. 454-462. |
| Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, Vol. 4, No. 1, 2002, pp. 25-33. |
| Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10. |
| Blendea, M. C., et al., “Heart Disease in Diabetic Patients”, Current Diabetes Reports, vol. 3, 2003, pp. 223-229. |
| Boyne, M. S., et al., “Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor”, Diabetes, vol. 52, Nov. 2003, pp. 2790-2794. |
| Bremer, T. M., et al., “Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418. |
| Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56. |
| Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671. |
| Cheyne, E. H., et al., “Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers”, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613. |
| Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2. Superiority of the One-Point Calibration Method”, Biosensors and Bioelectronics, vol. 17, No. 8, 2002, pp. 647-654. |
| Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244. |
| Dassau, E., et al., “Detection of a Meal Using Continuous Glucose Monitoring”, Emerging Treatments and Technologies, vol. 31, No. 2, Feb. 2008, pp. 295-300. |
| Diabetes Control and Complications Trial Research Group, “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus,” New England J. Med. vol. 329, 1993, pp. 977-986. |
| Eckert, B. et al. “Hypoglycaemia Leads to an Increased QT Interval in Normal Men,” Clinical Physiology, vol. 18, No. 6, 1998, pp. 570-575. |
| Eren-Oruklu, M., et al., “Estimation of Future Glucose Concentrations with Subject-Specific Recursive Linear Models”, Diabetes Technology & Therapeutics vol. 11(4), 2009, pp. 243-253. |
| Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779. |
| Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004. |
| Georgescu, B., et al., “Real-Time Multimodel Tracking of Myocardium in Echocardiography Using Robust Information Fusion”, Medical Image Computing and Computer-Assisted Intervention, 2004, pp. 777-785. |
| Goldman, J. M., et al., “Masimo Signal Extraction Pulse Oximetry”, Journal of Clinical Monitoring and Computing, vol. 16, No. 7, 2000, pp. 475-483. |
| Guerci, B., et al., “Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs”, Diabetes Care, vol. 26, 2003, pp. 582-589. |
| Harris, N.D., et al., “Can Changes in QT Interval be Used to Predict the Onset of Hypoglycemia in Type 1 Diabetes?”, Computers in Cardiology, vol. 27, 2000, pp. 375-378. |
| Heller, S. R., “Abnormalities of the Electrocardiogram During Hypoglycemia: The Cause of the Dead in Bed Syndrome?” International Journal of Clinical Practice, Suppl. No. 129, 2002, pp. 27-32. |
| Hovorka, R., et al., “Nonlinear Model Predictive Control of Glucose Concentration in Subjects with Type 1 Diabetes”, Physiological Measurement, vol. 55, Jul. 2004, pp. 905-920. |
| Hyunjin, L., et al., “A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator”, Journal of Diabetes Science and Technology, vol. 3, Issue 5, Sep. 2009, pp. 1082-1090. |
| Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652. |
| Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719. |
| Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198. |
| Jones, T. W., et al., “Mild Hypoglycemia and Impairment of Brain Stem and Cortical Evoked Potentials in Healthy Subjects,” Diabetes vol. 39, 1990, 1550-1555. |
| Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250. |
| Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304. |
| Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549. |
| Kovatchev, B. P., et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, 2004, pp. 1922-1928. |
| Kovatchev, B. P., et al., “Graphical and Numerical Evaluation of Continuous Glucose Sensing Time Lag”, Diabetes Technology & Therapeutics, vol. 11, No. 3, Feb. 2009, pp. 139-143. |
| Kuure-Kinsey, M., et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, New York City, 2006, pp. 63-66. |
| Landstedt-Hallin, L., et al., “Increased QT Dispersion During Hypoglycaemia in Patients with Type 2 Diabetes Mellitus,” Journal of Internal Medicine, vol. 246, 1999, 299-307. |
| Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 573-587. |
| Lortz, J., et al., “What is Bluetooth? We Explain The Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74. |
| Maher, “A Method for Extrapolation of Missing Digital Audio Data”, Preprints of Papers Presented at the AES Convention, 1993, pp. 1-19. |
| Maher, “Audio Enhancement using Nonlinear Time-Frequency Filtering”, AES 26th International Conference, 2005, pp. 1-9. |
| Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658. |
| Malmberg, K., “Prospective Randomised Study of Intensive Insulin Treatment on Long-Term Survival After Acute Myocardial Infarction in Patients with Diabetes Mellitus”, British Medical Journal, vol. 314, 1997, pp. 1512-1515. |
| Markel, A. et al., “Hypoglycaemia-Induced Ischaemic ECG Changes”, Presse Medicale, vol. 23, No. 2, 1994, pp. 78-79. |
| McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages. |
| McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376. |
| McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532. |
| Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263. |
| Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301. |
| Okin, P. M., et al., “Electrocardiographic Repolarization Complexity and Abnormality Predict All-Cause and Cardiovascular Mortality in Diabetes,” Diabetes, vol. 53, 2004, pp. 434-440. |
| Panteleon, A. E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration”, Diabetes Technology & Therapeutics, vol. 5, No. 3, 2003, pp. 401-410. |
| Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549. |
| Peterson, K., et al., “Regulation of Serum Potassium During Insulin-Induced Hypoglycemia,” Diabetes, vol. 31, 1982, pp. 615-617. |
| Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346. |
| Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217. |
| Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272. |
| Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161. |
| Rana, B. S., et al., “Relation of QT Interval Dispersion to the Number of Different Cardiac Abnormalities in Diabetes Mellitus”, The American Journal of Cardiology, vol. 90, 2002, pp. 483-487. |
| Robinson, R. T. C. E., et al. “Changes in Cardiac Repolarization During Clinical Episodes of Nocturnal Hypoglycaemia in Adults with Type 1 Diabetes,” Diabetologia, vol. 47, 2004, pp. 312-315. |
| Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241. |
| Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158. |
| Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322. |
| Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308. |
| Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299. |
| Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406. |
| Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184. |
| Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20. |
| Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313. |
| Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210. |
| Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301. |
| Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131. |
| Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942. |
| Steil, G. M., et al., “Closed-Loop Insulin Delivery—the Path of Physiological Glucose Control”, Advanced Drug Delivery Reviews, vol. 56, 2004, pp. 125-144. |
| Steil, G. M., et al., “Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor”, Diabetes Technology & Therapeutics, vol. 5, No. 1, 2003, pp. 27-31. |
| Steinhaus, B. M., et al., “The Information Content of the Cardiac Electrogram at the Stimulus Site,” Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 12, No. 2, 1990, 0607-0609. |
| Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40. |
| Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261. |
| Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115. |
| Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137. |
| Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964. |
| Whipple, G., “Low Residual Noise Speech Enhancement Utilizing Time-Frequency”, Proceedings of the International Conference on Acoustics, Speech, and Signal Processing, vol. 19, 1994, pp. I5-I8. |
| Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617. |
| Wolfe, P. J., et al., “Interpolation of Missing Data Values for Audio Signal Restoration Using a Gabor Regression Model”, 2005 IEEE International Conference on Acoustics, Speech, and Signal Processing, vol. 5, 2005, pp. 517-520. |
| U.S. Appl. No. 13/172,823, Advisory Action dated Nov. 7, 2014. |
| U.S. Appl. No. 13/172,823, Notice of Allowance dated Jun. 22, 2018. |
| U.S. Appl. No. 13/172,823, Office Action dated Aug. 7, 2014. |
| U.S. Appl. No. 13/172,823, Office Action dated Feb. 4, 2014. |
| U.S. Appl. No. 13/172,823, Office Action dated Nov. 25, 2015. |
| U.S. Appl. No. 13/172,823, Office Action dated Nov. 17, 2017. |
| U.S. Appl. No. 13/172,823, Office Action dated Sep. 6, 2016. |
| Number | Date | Country | |
|---|---|---|---|
| 20190029575 A1 | Jan 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61359774 | Jun 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13172823 | Jun 2011 | US |
| Child | 16152276 | US |
